Information for: Research Associates Students & Alumni Visitors

Population Aging Research Center

Home
About Us
- About Us
- Contact PARC
People
Research
Publications
Services
Resources
News & Events
Pilot Awards
- Pilot Awards
- Quartet Pilot Project Competition
Training
Allied Centers

NIH Funding Opportunities (Notices, PA, RFA)

Your Grant Application Questions Answered in New NIH Center for Scientific Review Videos
Clinical Trial Readiness for Rare Diseases, Disorders, and Syndromes (R21 Clinical Trial Not Allowed)
Clinical Trial Readiness for Rare Diseases, Disorders, and Syndromes (R03 Clinical Trial Not Allowed)
NIH funds specialized centers for child maltreatment research
Pre-application: Opportunities for Collaborative Research at the NIH Clinical Center (X02 Clinical Trial Optional)
Opportunities for Collaborative Research at the NIH Clinical Center (U01 Clinical Trial Optional)
Fc-Dependent Mechanisms of Antibody-Mediated Killing (R21 Clinical Trial Not Allowed)
Fc-Dependent Mechanisms of Antibody-Mediated Killing (U01 Clinical Trial Not Allowed)
National Dental Practice-Based Research Network: Clinical Trial or Observational Study Planning and Implementation Cooperative Agreement (UG3/UH3 Clinical Trial Optional)
NIH Offers Assistance to Active Phase I HHS SBIR and STTR Awardees through the Niche Assessment Program 2018-2019
Mechanisms of Disparities in Etiology and Outcomes of Lung Cancer in the U.S.: The Role of Risk and Protective Factors (R01 Clinical Trial Not Allowed)
Mechanisms of Disparities in Etiology and Outcomes of Lung Cancer in the U.S.: The Role of Risk and Protective Factors (R21 Clinical Trial Not Allowed)
Notice of Change in the Expiration Date for PAR-18-894, " Mental Health Research Dissertation Grant to Enhance Workforce Diversity (R36 Independent Clinical Trial Not Allowed) "
Notice To Clarify that Support of Competitive Research (SCORE) Awards are Eligible for Support through PA-18-936 "NIH Administrative Supplements to Recover Losses due to Hurricanes Harvey, Irma, and Maria Under the Bipartisan Budget Act of 2018"
Notice of Intent to Publish a Funding Opportunity Announcement for Botanical Dietary Supplements Research Centers (U19 Clinical Trial Optional)
Notice of Intent to Publish a Funding Opportunity Announcement for NMR Open Access Data Exchange (U24, Clinical Trial Not Allowed)
Notice of Intent to Publish a Funding Opportunity Announcement for Center for Natural Product Technology, Methodology and Productivity Optimization (NP-TEMPO) (U41, Clinical Trial Not Allowed)
Advancing Imaging, Device Production, and Clinical Capabilities in Digital Dentistry (R43/R44 Clinical Trial Not Allowed)
Advancing Imaging, Device Production, and Clinical Capabilities in Digital Dentistry (R41/R42 Clinical Trial Not Allowed)
Collaborative Research in Computational Neuroscience (CRCNS) Innovative Approaches to Science and Engineering Research on Brain Function
Notice of Participation of the National Institute on Aging (NIA) in PA-18-917 "Developing the Therapeutic Potential of the Endocannabinoid System for Pain Treatment (R01 - Clinical Trial Optional)"
Notice of Change to Budget Instructions for RFA-MH-18-704 "Development of Psychosocial Therapeutic and Preventive Interventions for Mental Disorders (R61/R33 Clinical Trial Required)"
BRAIN Initiative: Notice of Support for Research on the Fundamental Neurobiology of Endogenous Opioid Systems
Notice of Intent to Publish a Funding Opportunity Announcement for Limited Competition Adolescent Brain Cognitive Development (ABCD) Study Funding Opportunity Announcement - Data Analysis, Informatics, and Resource Center (U24)
Notice of Intent to Publish a Funding Opportunity Announcement for Limited Competition Adolescent Brain Cognitive Development (ABCD) Study Funding Opportunity Announcement - Research Project Sites (U01 - Clinical Trial Not Allowed)
Notice of Intent to Publish a Funding Opportunity Announcement for Limited Competition for Adolescent Brain Cognitive Development (ABCD) Study Funding Opportunity Announcement - Coordinating Center (U24 - Clinical Trial Not Allowed)
NIH research projects to track activities of gut-derived metabolites
Notice of Correction to Budget Requirements for RFA-AG-19-023, "Telomeres as Sentinels of Environmental Exposures, Psychosocial Stress, and Disease Susceptibility: A Methods Comparison Study (U01 Clinical Trial Optional)"
Request for Proposals (RFP) Notice: Toxicological Evaluations of Potential Medications
Notice of Intent to Publish a Funding Opportunity Announcement for Back Pain Consortium (BACPAC) Research Program: Phase 2 Clinical Trials (UG3/UH3) (Clinical Trial Required)
Notice of Intent to Publish a Funding Opportunity Announcement for Back Pain Consortium (BACPAC) Research Program Technology Research Sites (UH2/UH3) (Clinical Trial Optional)
Notice of Intent to Publish a Funding Opportunity Announcement for Back Pain Consortium (BACPAC) Research Program Data Integration, Algorithm Development and Operations Management Center (U24) (Clinical Trial Not Allowed)
Notice of Intent to Publish a Funding Opportunity Announcement for Back Pain Consortium (BACPAC) Research Program: Mechanistic Research Centers (U19) (Clinical Trial Optional)
Delayed pushing appears to have no effect on chances for spontaneous vaginal delivery
Gene mutation points to new way to fight diabetes, obesity, heart disease
Health-professional Education Partnership Initiative (HEPI) (R25 Clinical Trial Not Allowed)
Human Pancreas Analysis Program (HPAP) (U01 Clinical Trial Not Allowed)
Human Pancreas Analysis Program for Type-2 Diabetes (HPAP-T2D) (U01 Clinical Trial Not Allowed)
Request for Information (RFI) on Proposed Provisions for a Draft Data Management and Sharing Policy for NIH Funded or Supported Research
Archived Protecting Human Research Participants (PHRP) Training and Alternative Courses Reminder
NIH Online Clinical Research Courses are Now Open
Request for Information (RFI): Challenges and Opportunities for Understanding and Treating Small Cell Lung Cancer
Notice of Applicant Information Webinar for RFA-DA-19-013, "Responding to Opioid Use Disorders (OUD) in Tribal Communities in the Context of SAMHSA and CDC Funding (R61/R33 - Clinical Trials Optional)"
Notice of Pre-Application Technical Assistance Webinar for RFA-MD-18-012, Research Centers in Minority Institutions (RCMI) (U54 Clinical Trials Optional)
Notice of Joint DMS/NLM Initiative on Generalizable Data Science Methods for Biomedical Research.
Reinstatement of NIH SBIR Direct-to-Phase II Authority and Associated Updates to NIMH associated SBIR FOAs
Radiation Biodosimetry Assays and Devices (U01 Clinical Trial Not Allowed)
NIH study finds probiotic Bacillus eliminates Staphylococcus bacteria
Study identifies gene that makes gentle touch feel painful after injury
Understanding the Glycemic Profile of Pregnancy - Biostatistics Research Center (U01 Clinical Trial Not Allowed)
Understanding the Glycemic Profile of Pregnancy - Clinical Centers (U01 Clinical Trial Not Allowed)
Specialized Alcohol Research Centers Clinical Trial Optional (P50 Clinical Trial Optional)
Natural History Studies Addressing Unmet Needs of Rare Diseases: Orphan Products Research Project Grant (R01)
A Data Sharing Renaissance: Music to My Ears!
Scientists develop novel vaccine for Lassa fever and rabies
Notice of Intent to Publish a Funding Opportunity Announcement for Integrated Approach to Pain and Opioid Use in Hemodialysis Patients Clinical Sites (U01 Clinical Trial Required)
Notice of Intent to Publish a Funding Opportunity Announcement for Integrated Approach to Pain and Opioid Use in Hemodialysis Patients Scientific and Data Research Center (U01 Clinical Trial Required)
The Roles of Fellows and Trainees in NIH Supported Clinical Trials
Notice of Correction to RFA-DE-19-006 "National Dental Practice-Based Research Network: Clinical Trial or Observational Study Planning and Implementation Cooperative Agreement (UG3/UH3 Clinical Trial Optional)"
New NIH Peer Review Videos for Applicants
Notice of Correction of PA-18-870, "BRAIN Initiative: Development Optimization, and Validation of Novel Tools and Technologies for Neuroscience Research (STTR) (R41/R42 - Clinical Trials Not Allowed)"
Notice of Intent to Issue the Funding Opportunity Announcement for Bioengineering Research Grants (BRG) (R01 Clinical Trial Not Allowed)
Notice of Intent to Issue the Funding Opportunity Announcement for Bioengineering Research Grants (BRG) (R01 Clinical Trial Required)
New Grant Application Submission Tips for Success Videos
Notice of Intent to Issue the Funding Opportunity Announcement for Bioengineering Research Partnerships (U01 Clinical Trial Required)
Notice of Intent to Issue the Funding Opportunity Announcement for Bioengineering Research Partnerships (U01 Clinical Trial Not Allowed)
Addressing Caregiver Symptoms through Technological Tools (R21 Clinical Trial Optional)
Addressing Caregiver Symptoms through Technological Tools (R01 Clinical Trial Optional)
Diabetes Research Centers (P30)
Notice of Change to Activity Codes allowed for Administrative Supplements to Promote Diversity in Research and Development Small Businesses-SBIR/STTR (Admin Supp Clinical Trial Not Allowed) PA-18-837
Enhancing Data Management and Sharing in NIEHS-Funded Research Grants (Admin Supp Clinical Trial Not Allowed)
NIH programs shed light on gene variants and their connections to health and disease
Notice of Correction to Application Types Allowed" in PAR-18-522 NEI Collaborative Clinical Vision Project: Resource Center Grant (UG1- Clinical Trial Required)
Notice of Correction to Application Types Allowed" in PAR-18-523 NEI Collaborative Clinical Vision Research Project : Chair's Grant (UG1-Clinical Trial Required)
Notice of Correction to Application Types Allowed" in PAR-18-521 NEI Collaborative Clinical Vision Research Project: Coordinating Center Grant (UG1- Clinical Trial Required)
Notice of Clarification: Research Strategy page limit for RFA-NS-18-046 Analytical and/or Clinical Validation of a Candidate Biomarker for Pain (R61/R33 Clinical Trial Optional)
Notice of Clarification: Research Strategy page limit for PAR-18-548, Clinical Validation of a Candidate Biomarker for Neurological Disease (U44 Clinical Trial Optional)
Notice of Clarification: Research Strategy page limit for PAR-18-664, Clinical Validation of a Candidate Biomarker for Neurological Disease (U01 Clinical Trial Optional)
Notice of Clarification: Research Strategy page limit for PAR-18-550, Analytical Validation of a Candidate Biomarker for Neurological Disease (U01) (Clinical Trial Optional)
Notice of Clarification: Research Strategy page limit for PAR-18-549, Analytical Validation of a Candidate Biomarker for Neurological Disease (U44 Clinical Trial Optional)
REQUEST FOR PROPOSAL (RFP): BIOINFORMATICS RESOURCE CENTERS FOR INFECTIOUS DISEASES, RFP-NIAID-DMID-NIHAI201800005
Reinstatement of NIH SBIR Direct-to-Phase II Authority and Associated Updates to PAR-18-801 Cancer Prevention, Diagnosis, and Treatment Technologies for Low-Resource Settings (R43/R44 - Clinical Trial Optional)
Reinstatement of NIH SBIR Direct-to-Phase II Authority and Associated Updates to PAR-18-303 Innovative Molecular Analysis Technology Development for Cancer Research and Clinical Care (R43/R44 Clinical Trial Not Allowed)
Notice to allow SBIR Direct-to-Phase II Application Type for NIAAA-issued Funding Opportunity Announcement PAR-18-786, "Wearable Alcohol Biosensors (SBIR) (R43/R44- Clinical Trial Optional)"
Reinstatement of NIH SBIR Direct-to-Phase II Authority and Associated Updates to NIH SBIR Omnibus Solicitations
Notice of Intent to Publish a Funding Opportunity Announcement for Tissue Chips to Model Nociception, Addiction, and Overdose (UG3/UH3 Clinical Trial Not Allowed)
Reinstatement of NIH SBIR Direct-to-Phase II Authority and Associated Updates to NCATS Platform Delivery Technologies for Nucleic Acid Therapeutics (R43/R44) Funding Opportunity Announcement
Antibody combination suppresses HIV
Fecal transplants restore gut microbes after antibiotics
Wearable ultrasound patch tracks blood pressure
Lymphatics in Health and Disease in the Digestive System (R01 Clinical Trial Not Allowed)
New “All About Grants” Podcast on Preparing for Private Investment
Notice of Intent to Publish a Funding Opportunity Announcement for Basic Research on Sleep and Circadian-Dependent Mechanisms Contributing to Opiate Use Disorder (OUD) and Response to Medication Assisted Treatment (MAT) (R01 - Clinical Trial Not Allowed)
Notice of Intent to Publish a Funding Opportunity Announcement for Clinical Research on Sleep and Circadian-Dependent Mechanisms Contributing to Opiate Use Disorder (OUD) and Response to Medication Assisted Treatment (MAT) - (U01 Clinical Trial Optional)
Request for Information (RFI) on the Proposed Funding Priorities for Neuroscience Research, Input on Cross-Cutting Opportunities (NIH Neuroscience Blueprint)
Basic Neurodevelopmental Biology of Brain Circuits and Behavior (R21 Clinical Trial Not Allowed)
Basic Neurodevelopmental Biology of Circuits and Behavior (R01 Clinical Trial Not Allowed)
Responsibilities of Recipient Institutions in Communicating Research Misconduct to the NIH
Innovation Corps (I-Corps) at NIH Program for NIH and CDC Translational Research (Admin Supp Clinical Trial Not Allowed)
Researchers identify immune culprits linked to inflammation and bone loss in gum disease
Notice of Webinar and FAQs for NIAID Vaccine and Treatment Evaluation Units (UM1 Clinical Trial Required) and Leadership Group for an Infectious Diseases Clinical Research Consortium (IDCRC) (UM1 Clinical Trial Required), RFA-AI-18-046 and RFA-AI-18-047
NIDDK Education Program Grants (R25 Clinical Trial Not Allowed)
Notice of Intent to Publish a Funding Opportunity Announcement to Support Biofabricated 3D Tissue Models of Nociception, Opioid Use Disorder and Overdose for Drug Screening (UH2/UH3 Clinical Trial Not Allowed)
BRAIN Initiative: Research on the Ethical Implications of Advancements in Neurotechnology and Brain Science (R01 Clinical Trial Optional)
Notice of Intent to Publish a Funding Opportunity Announcement for the Development, Implementation, and Management of a Funding System to support the Grade A Milk Safety Program and National Shellfish Sanitation Program
Genomic analysis offers insight into 2018 Nigeria Lassa fever outbreak
Administrative Supplements for Complementary Health Practitioner Research Experience (Admin Supp Clinical Trial Optional)
NIH to develop uniform standards, seek independent input for relocation of at-risk chimpanzees
In an interview with United for Medical Research’s Amazing Things podcast, Dr. Collins discusses NIH’s top priorities
Expert Panel Meeting to Discuss Study Design for a Longitudinal Study of the Impact of Prenatal Opioid and other Substance Exposure on Brain and Behavioral Development
Notice of Availability of Administrative Supplements for Microphysiological Systems Developers : Development of Tissue Chips to Model Nociception, Opioid Addiction and Overdose
Notice of Information: Re-Opening the Comment Period for an NIH Proposal to Amend the NIH Guidelines for Research Involving Recombinant or Synthetic Nucleic Acid Molecules to Streamline Oversight of Human Gene Transfer Protocols
Reminder: NIH Natural Disaster Policy - Hurricane Michael
Notice of Intent to Publish a Funding Opportunity Announcement for Translational Devices to Treat Pain (U44 Clinical Trial Optional)
Reinstatement of NIH SBIR Direct-to-Phase II Authority and Associated Updates to NIGMS SBIR FOAs
BRAIN Initiative: Research Resource Grants for Technology Integration and Dissemination (U24 Clinical Trial Not Allowed)
Notice of Intent to Publish a Funding Opportunity Announcement for Development of Translational Devices to Treat Pain (U18 Clinical Trial Not Allowed)
Common use of antipsychotics shown ineffective for delirium in intensive care patients
How gentle touch can turn painful after injury
Probiotic bacteria block harmful microbe
Delayed pushing doesn’t help during labor
Notice Announcing NIEHS Use of PA-18-935 "Urgent Competitive Revision to Existing NIH Grants and Cooperative Agreements (Urgent Supplement - Clinical Trial Optional)" for Hurricanes Florence and Michael Research Response
Notice Announcing NIEHS Use PA-18-591 "Administrative Supplements to Existing NIH Grants and Cooperative Agreements (Parent Admin Supp Clinical Trial Optional)" for Hurricane Florence Research Response
Notice Announcing NIEHS Use of RFA-ES-16-005 "Mechanism for Time-Sensitive Research Opportunities in Environmental Health Sciences (R21)" for Hurricanes Florence and Michael Response Research
NICHD Policy on Monitoring and Oversight of Clinical Trials
Notice of NIGMS Participation in PA-19-029 Innovation Corps (I-Corps) at NIH Program for NIH and CDC Translational Research (Admin Supp Clinical Trial Not Allowed)
Notice to Extend PAR-18-942 Neuromodulation/Neurostimulation Device Development for Mental Health Applications (R01 Clinical Trial Optional)
Notice to Extend PAR-18-941 Neuromodulation/Neurostimulation Device Development for Mental Health Applications (R21 Clinical Trial Optional)
Notice of NHLBI Participation in PA-19-029 "Innovation Corps (I-Corps) at NIH Program for NIH and CDC Translational Research (Admin Supp Clinical Trial Not Allowed) issued by the National Institutes of Health.
Notice of Participation of the National Institute on Aging (NIA) in PAR-18-714, "Academic Research Enhancement Award for Undergraduate-Focused Institutions (R15 - Clinical Trial Not Allowed)"
PRE-SOLICITATION NOTICE: SIMIAN VACCINE EVALUATION UNITS (SVEUs)
Publication of the Revised NIH Grants Policy Statement (Rev. October 2018) for FY 2019
Notice to Clarify the Participation of Foreign Scientists in PAR-17-340 "Collaborative Program Grant for Multidisciplinary Teams (RM1)"
Notice Inviting the Community to Contribute to the Generation of NHGRI's '2020 Vision for Genomics'
Presolicitation Notice: Request for Proposals (RFP) N01CN87006-18 "PREVENT Cancer Preclinical Drug Development Program: cGMP Production of Vaccines and Biologicals for Cancer Prevention"
Reinstatement of NIH SBIR Direct-to-Phase II Authority and Associated Updates to NHGRI Associated SBIR FOAs
Notice of Intent to Publish a Funding Opportunity Announcement for Translational Devices to Treat Pain (UG3/UH3 Clinical Trial Optional)
Notice of NIDA's participation in PAR-18-836 "Global Brain and Nervous System Disorders Research Across the Lifespan (R21 Clinical Trial Optional)"
Notice for a Pre-application Webinar for Biospecimen Funding Opportunity Announcement PAR-18-947 (U01)
Notice of NIDA's participation in PAR-18-835 "Global Brain and Nervous System Disorders Research Across the Lifespan (R01 Clinical Trial Optional)"
Notice of NIH Participation in the Ecology and Evolution of Infectious Diseases Program
Request for Information (RFI): Understanding the Health of Women and the Role of Sex/Gender in Mechanisms of Heart, Lung, Blood, and Sleep Diseases and Disorders
Request for Information (RFI): Soliciting input for future research at the NHLBI regarding Late complications after allogeneic hematopoietic stem cell transplantation or autologous gene modified stem cell transplant for non-malignant blood disorders
A Census of Cells and Circuits in the Aging Brain (R01 Clinical Trial Not Allowed)
Notice of Intent to Publish a Funding Opportunity Announcement for Physical Sciences-Oncology Network (PS-ON): Physical Sciences-Oncology Projects (PS-OP) (U01 Clinical Trial Optional)
Clinical Studies of Orphan Products Addressing Unmet Needs of Rare Diseases (R01)
Notice of Clarification of Award Budget for PAR-18-656 NIDCR Behavioral and Social Intervention Clinical Trial Planning and Implementation Cooperative Agreement (UG3/UH3 Clinical Trial Required)
NLM Grants for Scholarly Works in Biomedicine and Health (G13 Clinical Trial Not Allowed)
Notice of Correction to Revise Application Due Dates for PAR-18-910 Limited Competition for NIH-Industry Program: Discovering New Therapeutic Uses for Existing Molecules (U01 Clinical Trial Required)
Myo-inositol unlikely to reduce risk of eye complication in preterm infants
Amazon Web Services joins NIH’s STRIDES Initiative to harness latest cloud technologies for biomedical researchers
NIH selects first scholars in pioneering program to enhance diversity within in-house research program
Commercializing Understudied Proteins from the Illuminating the Druggable Genome Project (IDG) (R41/R42 Clinical Trial Not Allowed)
Commercializing Understudied Proteins from the Illuminating the Druggable Genome Project (IDG) (R43/R44 Clinical Trial Not Allowed)
Notice of Correction to Revise Application Due Dates for NOT-TR-19-001 Notice of Availability of Administrative Supplements for Microphysiological Systems Developers: Development of Tissue Chips to Model Nociception, Opioid Addiction and Overdose
Administrative Supplements to Cancer Center Support Grants to Strengthen NCI-Supported Community Outreach Capacity through Community Health Educators of the National Outreach Network (Admin Suppl Clinical Trial Not Allowed)
Notice of NIDCD Participation in PAR-18-714-Academic Research Enhancement Award for Undergraduate-Focused Institutions (R15 - Clinical Trial Not Allowed)
Notice of Change to Application Due Date for Administrative Supplement for the NINDS Research Education Program for Residents and Fellow in Neurosurgery, Neuropathology, Neuroradiology and Emergency Medicine (Admin Supplement)
Request for Information (RFI): Guidance on Current Clinical Experience with the Use of Ketamine for Suicide Prevention
Notice of NCCIH Participation in PAR-18-714, "Academic Research Enhancement Award for Undergraduate-Focused Institutions (R15 - Clinical Trial Not Allowed)"
NIDDK Targeted SBIR Funding Opportunity Announcements Modified to Allow SBIR Direct-to-Phase II Applications
Notice of Change in Application Due Date for PAR-17-001 "Emerging Global Leader Award (K43)"
Reproductive Medicine Collaborative Clinical Trials Program (Collaborative R01 Clinical Trial Required)
Dr. Collins shares his view on how to live a meaningful life with Esquire
Initiative for Maximizing Student Development (IMSD) (T32)
Medical Scientist Training Program (T32)
Changes in NIGMS Support of Integrated Predoctoral Dual-degree M.D.-Ph.D. Training through the Medical Scientist Training Program
Emerging Global Leader Award (K43 Independent Clinical Trial Required)
Early Screening for Autism Spectrum Disorder (R21 Clinical Trial Not Allowed)
Early Screening for Autism Spectrum Disorder (R01 Clinical Trial Not Allowed)
Notice of Intent to Publish a Funding Opportunity Announcement for Human Genome Reference Center (HGRC) (U41 Clinical Trial Not Allowed)
Notice of Intent to Publish a Funding Opportunity Announcement for Research and Development for Genome Reference Representations (GRR) (U01, Clinical Trial Not Allowed)
Notice of Intent to Publish a Funding Opportunity Announcement for High Quality Human Reference Genomes (HQRG) (UM1 Clinical Trial Not Allowed)
Notice of Change to Funding Opportunity Announcement, RFA-MD-18-012 Research Centers in Minority Institutions (RCMI) (U54 Clinical Trials Optional)" Regarding Late Applications
Notice of Information: NIMHs Interest in Areas of Stress Biology Research
Development of Personalized In Vitro Assays to Quantitatively Assess Age-related Changes in Cellular Resiliencies to Physiologic Stressors (R41/R42 Clinical Trial Not Allowed)
Development of Personalized In Vitro Assays to Quantitatively Assess Age-related Changes in Cellular Resiliencies to Physiologic Stressors (R43/R44 Clinical Trial Not Allowed)
Notice of Pre-Application Technical Assistance Webinar for RFA-HD-19-022, Reproductive Medicine Collaborative Clinical Trials Program (Collaborative R01 Clinical Trial Required)
NINDS Morris K. Udall Centers of Excellence for Parkinsons Disease Research (P50 Clinical Trial Optional)
NINDS Morris K. Udall Center without Walls for Parkinsons Disease Research (P20 Clinical Trial Optional)
Notice of Intent to Publish Parent Funding Opportunity Announcements for Basic Experimental Studies with Humans
Countermeasures Against Chemical Threats (CounterACT): Optimization of Therapeutic Lead Compounds (U01 Clinical Trial Optional)
Countermeasures Against Chemical Threats (CounterACT): Identification of Therapeutic Lead Compounds (U01 Clinical Trial Not Allowed)
Lewy Body Dementia Center Without Walls (CWOW) (U54 Clinical Trial Not Allowed)
Limited Competition: Extramural Research Facilities Restoration Program: Hurricanes Harvey, Irma, and Maria Disaster Relief (C06 Clinical Trial Not Allowed)
Limited Competition: Restoring Research Resources Lost or Damaged Due to Hurricanes Harvey, Irma, and Maria (R24 Clinical Trial Optional)
Notice of Clarification Regarding Letters of Support for PAR-17-025, "Aging Research Dissertation Awards to Increase Diversity (R36)"
Notice of NIA Participation in PAR-18-881 "Short-term Mentored Career Enhancement Awards in Mobile and Wireless Health Technology and Data Analytics: Cross-training at the Intersection of Behavioral and Social Sciences and STEM Disciplines"
Notice of Intent to Publish for Effectiveness Trials to Optimize, Implement, Scale, and Sustain the Collaborative Care Model for Individuals with Opioid Use Disorders and Mental Health Conditions (U01 Clinical Trials Required)
Notice of NIDCR Participation in PAR-17-097 Planning for Non-Communicable Diseases and Disorders Research Training Programs in Low and Middle Income Countries (D71)
Notice of Change to PAR-18-952 Clinical Trial Readiness for Rare Diseases, Disorders, and Syndromes (R03 Clinical Trial Not Allowed)
Notice of NIDCR Participation in PAR-18-901 Chronic, Non-Communicable Diseases and Disorders Across the Lifespan: Fogarty International Research Training Award (NCD-LIFESPAN) (D43 Clinical Trial Optional)
Notice of NIA Participation in PAR-18-882 "Short-term Mentored Career Enhancement Awards in Mobile and Wireless Health Technology and Data Analytics: Cross-training at the Intersection of Behavioral and Social Sciences and STEM Disciplines"
Revised Process for SBIR/STTR Life Cycle Certifications
Notice of Change to PAR-18-953 Clinical Trial Readiness for Rare Diseases, Disorders, and Syndromes (R21 Clinical Trial Not Allowed)
Notice of Change to Activity Codes allowed for NIH Administrative Supplements to Recover Losses Due to Hurricanes Harvey, Irma, and Maria Under the Bipartisan Budget Act of 2018 - Non- Construction (Admin Supp Clinical Trial Optional) PA-18-936
Request for Information (RFI): Soliciting Input on Priorities and Progress in Alzheimer's Disease-Related Dementias Research
Statement on NHLBI decision to pause the CONCERT-HF trial
Astrocytes regulate signal speeds of neurons
Vaccine protects animals against anthrax and plague
Immune culprits linked to inflammation and bone loss in gum disease
Antipsychotics not helpful for delirium in ICU
Notice of NIEHS Participation in PAR-18-714 "Academic Research Enhancement Award for Undergraduate-Focused Institutions (R15 - Clinical Trial Not Allowed)"
Notice to Extend the Expiration Date and Change Receipt Dates for PAR-18-836 Global Brain and Nervous System Disorders Research Across the Lifespan (R21 Clinical Trial Optional)
Notice to Extend the Expiration Date and Change Receipt Dates for PAR-18-835 Global Brain and Nervous System Disorders Research Across the Lifespan (R01 Clinical Trials Optional)
Building in vivo Preclinical Assays of Circuit Engagement for Application in Therapeutic Development (R01 Clinical Trial Not Allowed)
Promoting Research on Music and Health: Phased Innovation Award for Music Interventions (R61/R33 Clinical Trial Optional)
Promoting Research on Music and Health: Fundamentals and Applications (R01 Clinical Trials Optional)
Promoting Research on Music and Health: Fundamentals and Applications (R21 Clinical Trials Optional)
Centers on the Demography and Economics of Aging (P30 Clinical Trial Optional)
Centers on the Demography and Economics of Alzheimer's Disease and Alzheimer's Related Dementias (P30 Clinical Trial Optional)
Demography and Economics of Aging and AD-ADRD Coordinating Center (R24 Clinical Trial Not Allowed)
Notice of NIAAA's participation in PAR-18-714, Academic Research Enhancement Award for Undergraduate-Focused Institutions (R15-Clinical Trial Not Allowed)
Notice of NHLBI Participation in PAR-18-714-Academic Research Enhancement Award for Undergraduate-Focused Institutions (R15 - Clinical Trial Not Allowed)
Immuno-Oncology Translation Network (IOTN): Cancer Immunoprevention Research Projects (UG3/UH3)
Immuno-Oncology Translation Network (IOTN): Immuno-engineering to Improve Immunotherapy (i3) Centers (U54 Clinical Trial Not Allowed)
Immuno-Oncology Translation Network (IOTN): Cancer Immunoprevention Research Projects (U01 Clinical Trial Not Allowed)
Immuno-Oncology Translation Network (IOTN): Cancer Immunotherapy Research Projects (U01 Clinical Trial Not Allowed)
Human Islet Research Network - Consortium on Targeting and Regeneration (HIRN-CTAR) (U01 Clinical Trial Not Allowed)
What Contributes to the Success of Early Career Scientists? – A NIAID Look
Spring Into Action and Register for the 2019 NIH Regional Seminar in Baltimore Today!
End-of-Life and Palliative Care Approaches to Advanced Signs and Symptoms (R21- Clinical Trial Optional)
End-of-Life and Palliative Care Approaches to Advanced Signs and Symptoms (R01 Clinical Trial Optional)
Advancing Research in Augmentative and Alternative Communication (AAC) (R01 Clinical Trial Optional)
Advancing Research in Augmentative and Alternative Communication (AAC) (R21 Clinical Trial Optional)
Novel Approaches for Relating Genetic Variation to Function and Disease (R43/R44 Clinical Trial Not Allowed)
Gut bacteria may control movement
Engaging Men in HIV Testing, Prevention, and Care (R01 Clinical Trial Optional)
Engaging Men in HIV Testing, Prevention, and Care (R21 Clinical Trial Optional)
Accelerating Colorectal Cancer Screening and follow-up through Implementation Science (ACCSIS)(UG3/UH3 Clinical Trial Required)
NHLBI TOPMed: Omics Phenotypes of Heart, Lung, and Blood Disorders (X01 - Clinical Trial Not Allowed)
Update to NIH Management of Genomic Summary Results Access
This National Diabetes Month, care for your health after gestational diabetes
New Research Directions that Advance the NHLBI Strategic Vision Normal Biology (R21 - Clinical Trial Not Allowed)
High exposure to radio frequency radiation associated with cancer in male rats
NIH to fund national data collection on new mothers with disabilities
NIH BRAIN Initiative debuts cell census of mouse motor cortex – for starters
Alzheimer's Disease Research Centers (P30 Clinical Trial Not Allowed)
Protecting Participants, Empowering Researchers: Providing Access to Genomic Summary Results
Emerging Global Leader Award (K43 Independent Clinical Trial Required)
Notice of Intent to Publish a Funding Opportunity Announcement for Pragmatic and Implementation Studies for the Management of Pain to Reduce Opioid Prescribing (PRISM) (UG3/UH3, Clinical Trials Optional)
Notice of Intent to Publish a Funding Opportunity Announcement for Pragmatic Randomized Controlled Trial of Acupuncture for Management of Chronic Low Back Pain in Older Adults (UG3/UH3, Clinical Trial Required)
Notice of Intent to Publish a Funding Opportunity Announcement for Behavioral Research to Improve MAT: Behavioral and Social Interventions to Improve Adherence to Medication Assisted Treatment for Opioid Use Disorders (R61/R33, Clinical Trials Optional)
Notice of Intent to Publish a Funding Opportunity Announcement for Limited Competition: Behavioral Research to Improve MAT: Ancillary Studies to Enhance Behavioral or Social Interventions to Improve Adherence to Medication Assisted Treatment for OUD (R01)
NIH greatly expands investment in BRAIN Initiative
Optimization of Non-addictive Therapies [Small Molecules and Biologics] to Treat Pain (UG3/UH3 Clinical Trial Not Allowed)
Collaborative Study on the Genetics of Alcoholism (COGA) (Clinical Trial Not Allowed U10)
NIH Exploratory/Developmental Research Grant Program (Parent R21 Clinical Trial Required)
NIH Exploratory/Developmental Research Grant Program (Parent R21 Clinical Trial Not Allowed)
Research Project Grant (Parent R01 Clinical Trial Not Allowed)
Research Project Grant (Parent R01 Clinical Trial Required)
Notice Announcing Frequently Asked Questions Page and Webinar for PA-18-932 "Increasing Uptake of Evidence-Based Screening in Diverse Adult Populations (R01 Clinical Trial Optional)"
Request for Information (RFI): Soliciting Input on the National Institutes of Allergy and Infectious Diseases (NIAID) New Innovator Awards (DP2 Clinical Trials Optional)
Notice of NINDS Policy for Submission of Applications to PA-19-055 "NIH Research Project Grant (Parent R01 Clinical Trial Required). NINDS Only accepts Clinical Trial Applications Proposing Mechanistic Studies for Clinical Trial Parent R01
NIH Small Research Grant Program (Parent R03 Clinical Trial Not Allowed)
Preserving sperm stem cells restores fertility in mice
Method identifies disease-causing bacteria
How the brain keeps track of time
NIGMS Support of Predoctoral Training in Computational Biology, Bioinformatics, and Biomedical Data Science
NIMHD selects recipients for the William G. Coleman Jr., Ph.D., Minority Health and Health Disparities Research Innovation Award
NIH, Amgen Foundation, and FNIH renew support for undergraduate research opportunities
NINR Clinical Trial Planning Grant (R34 Clinical Trial Required)
NIA Intervention Testing Program (ITP) Announces Annual Call for Compounds to Test for Anti-Aging Activity in Mice
Notice of NICHD's Participation in PA-19-029 "Innovation Corps (I-Corps) at NIH Program for NIH and CDC Translational Research (Admin Supp Clinical Trial Not Allowed)
Notice of NICHD's Participation in PA-18-939 "Research on Chronic Overlapping Pain Conditions (R21 Clinical Trial Not Allowed)
Notice of NICHD's Participation in PA-18-937 "Research on Chronic Overlapping Pain Conditions (R01 Clinical Trial Optional)
Notice of Change in Key Dates in RFA-NS-18-026 "NINDS Morris K. Udall Centers of Excellence for Parkinson's Disease Research (P50 Clinical Trial Optional)"
Notice of Change in Key Dates in RFA-NS-18-027 "Exploratory Grant for NINDS Morris K. Udall Parkinson's Disease Research Center Without Walls (P20 Clinical Trial Optional)"
Strategies to Provide Culturally Tailored Palliative and End-of-Life Care for Seriously Ill American Indian and Alaska Native Individuals (R01 Clinical Trial Optional)
Strategies to Provide Culturally Tailored Palliative and End-of-Life Care for Seriously Ill American Indian and Alaska Native Individuals (R21 Clinical Trial Optional)
Addition of SBIR Direct-to-Phase II Program to NIA PAS-18-187, "Advacing Research on Alzheimer's Disease (AD) and AD-Related Dementias (ADRD) (R43/R44 Clinical Trial Optional)"
Notice of Intent to Publish a Funding Opportunity Announcement for Exploring the Mechanisms Underlying Analgesic Properties of Minor Cannabinoids and Terpenes (R21, Clinical Trial Optional)
Notice of Intent to Publish a Funding Opportunity Announcement for Exploring the Mechanisms Underlying Analgesic Properties of Minor Cannabinoids and Terpenes (R01, Clinical Trial Optional)
Notice of Change to PAR-18-940 Clinical and Translational Science Award (U54 Clinical Trial Optional)
Reinstatement of NIH SBIR Direct-to-Phase II Authority and Associated Updates to NIH SBIR Omnibus Solicitations
Reinstatement of NIH SBIR Direct-to-Phase II Authority and Associated Updates to NIH FOA PA-17-147
Harassment and Discrimination Protections in NIH Training Applications
Notice of Further Amendment of PAR-18-919 "Quantitative Imaging Tools and Methods for Cancer Response Assessment (R01 Clinical Trial Optional)"
Global Noncommunicable Diseases and Injury Across the Lifespan: Exploratory Research (R21 Clinical Trials Optional)
Novel antibiotic shows promise in treatment of uncomplicated gonorrhea
Notice of Correction to Key Dates for RFA-NS-19-002 "BRAIN Initiative: Team-Research BRAIN Circuit Programs - TeamBCP (U19 Clinical Trial Required)"
Notice of Correction to Key Dates for RFA-NS-19-003 "BRAIN Initiative: Team-Research BRAIN Circuit Programs - TeamBCP (U19 Clinical Trial Not Allowed)"
Notice of NIBIB's participation in PAR-18-714, "Academic Research Enhancement Award for Undergraduate-Focused Institutions (R15 - Clinical Trial Not Allowed)"
Notice of Change in Receipt Date for the Emerging Global Leader Award (K43) (Independent Clinical Trial Not Allowed)
Notice of Expiration of PA-18-474 "Self-Management for Health in Chronic Conditions (R15 Clinical Trial Not Allowed)"
Notice of Clarification to Language for Project Characteristics in PAR-18-550, Analytical Validation of a Candidate Biomarker for Neurological Disease (U01 Clinical Trial Optional)
Notice of Clarification to Language for Project Characteristics in PAR-18-549, Analytical Validation of a Candidate Biomarker for Neurological Disease (U44 Clinical Trial Optional)
Correction of Due Dates for Letters of Intent for PAR-18-930 Development and Optimization of Tasks and Measures for Functional Domains of Behavior (R01)
Notice of Updated Application Forms Package for NIBIB Supplements to NCATS CTSA Programs to Support NIBIB Translational Research Scholars (Admin Supp Clinical Trial Optional)
Addition of SBIR Direct-to-Phase II Program to PAR-18-588, Assistive Technology for Persons with Alzheimers Disease and Related Dementias and Their Caregivers (R43/R44 Clinical Trial Optional)"
Notice of Changes to RFA-AG-19-020 "Clinical Trial on Effects of Statins in Older Adults without Clinical Cardiovascular Disease (U19 Clinical Trial Required)"
Investigator Initiated Research in Computational Genomics and Data Science (R43/R44 Clinical Trial Not Allowed)
Data Coordinating Center for the Diabetic Foot Consortium (U24 Clinical Trial Not Allowed)
More adults and children are using yoga and meditation
Mechanism for Time-Sensitive Drug Abuse Research (R21 Clinical Trial Optional)
Notice of Legislative Mandates in Effect for FY 2019
Revised NIH Grants Policy Statement for Fiscal Year 2019
Soy formula feeding during infancy associated with severe menstrual pain in adulthood
New Application Requirements for Institutional Training Grants: Letter of Institutional Commitment to Harassment and Discrimination Protections
Single-Cell Multi-Omics of HIV Persistence (R01 Clinical Trial Not Allowed)
Medical Simulators for Practicing Patient Care Providers Skill Acquisition, Outcomes Assessment and Technology Development (R01 Clinical Trial Not Allowed)
Understanding Age in the NIH Portfolio: Implementation of the NIH Inclusion Across the Lifespan Policy
Processing and Presentation of Non-Conventional MHC Ligands (R01 Clinical Trial Not Allowed)
Processing and Presentation of Non-Conventional MHC Ligands (R21 Clinical Trial Not Allowed)
Legislative Mandates for Fiscal Year 2019
Secondary Analysis of Existing Datasets for Advancing Infectious Disease Research (R21 Clinical Trial Not Allowed)
NIH scientists illuminate causes of hepatitis b virus-associated acute liver failure
Request for Information (RFI) on the National Institute on Aging (NIA) Strategic Directions for Research
Request for Information (RFI) on Optimal Duration of Medication Treatment for Opioid Use Disorder
NCI Request for Information (RFI): Input to Advance Computational Approaches in Cancer Prevention Science
NIH scientists combine technologies to view the retina in unprecedented detail
Implementation Science for Cancer Control: Advanced Centers (P50 Clinical Trial Optional)
Implementation Science for Cancer Control: Developing Centers (P50 Clinical Trial Optional)
Enabling Technologies to Accelerate Development of Oral Biodevices (R01 Clinical Trial Not Allowed)
Enabling Technologies to Accelerate Development of Oral Biodevices (R21 Clinical Trial Not Allowed)
Notice of Pre-Application Webinar for RFA-AG-19-025 and RFA-AG-19-026, "Development of Personalized In Vitro Assays to Quantitatively Assess Age-related Changes in Cellular Resiliencies to Physiologic Stressors (SBIR/STTR)"
Decoding NIH Grant Numbers
Multi-project Application Resources
Request for Proposals (RFP) N01CN87006-18 "PREVENT Cancer Preclinical Drug Development Program: cGMP Production of Vaccines and Biologicals for Cancer Prevention"
Working Together to Protect the Integrity of NIH-funded Research
Notice of NIDCD participation effective immediately in PA-19-056 NIH Research Project Grant (R01-Clinical Trial Not Allowed)
Notice to Extend PAR-18-267 "Pilot Services Research Grants Not Involving Interventions (R34 Clinical Trial Optional)"
Notice of Correction to RFA-DA-19-009, Modeling HIV Neuropathology Using Microglia from Human iPSC and Cerebral Organoids (R01 Clinical Trial Not Allowed)
Notice of Correction to RFA-DA-19-010 , Modeling HIV Neuropathology Using Microglia from Human iPSC and Cerebral Organoids (R21 Clinical Trials Not Allowed)
Medications Development for the Treatment of Alcohol Use Disorder (U01 Clinical Trial Optional)
Research on Current Topics in Alzheimer's Disease and Its Related Dementias (R21 Clinical Trial Not Allowed)
Research on Current Topics in Alzheimer's Disease and Its Related Dementias (R01 Clinical Trial Optional)
NIH to Host Second Informational Webinar on Proposed Key Provisions for a Future Draft Data Management and Sharing Policy
Small Research Grants for Analyses of Data for the Gabriella Miller Kids First Data Resource (R03 - Clinical Trial Not Allowed)
Notice of NEI Participation in PAR-19-056 "Research Project Grant (Parent R01 Clinical Trial Not Allowed)"
Notice of NEI Withdrawal from Participation in PAR-19-055 "Research Project Grant (Parent R01 Clinical Trial Required)"
Notice of NIMH's Participation in PA-19-055 "Research Project Grant (Parent R01 Clinical Trial Required)
Study explains behavioral reaction to painful experiences
Notice of Correction to Cover Instructions for RFA-DK-18-501 Limited Competition for the Continuation of the Childhood Liver Disease Research Network (ChiLDReN) Clinical Centers (U01 Clinical Trial Required)
Notice of Updated Application Forms Package for PA-18-920, NCCIH Supplements to NCATS CTSA Programs for Scholars Pursuing Complementary Health Research Career Development (Admin Supp Clinical Trial Optional)
Data Science Research: Personal Health Libraries for Consumers and Patients (R01 Clinical Trial Optional)
Notice of NIMH's Participation in PA-19-054 " NIH Exploratory/Developmental Research Grant Program (Parent R21 Clinical Trial Required)
Appendix linked to toxic Parkinson’s protein
Building an atlas of brain function in mice
New antibiotic for gonorrhea advances in trials
Notice of Intent to Publish a Funding Opportunity Announcement for Research Evaluation and Commercialization Hubs (REACH) program
Telomeres in Wellness and Disease: A Biobehavioral Approach (R21 Clinical Trial Optional)
Telomeres in Wellness and Disease: A Biobehavioral Approach (R01 Clinical Trial Optional)
Notice to Specify High-Priority Research Topic for PAR-19-070 and PAR-19-071
Notice to Specify High-Priority Research Topic for PAR-19-070 and PAR-19-071
Notice of Amendment of PA-17-211, Nutrition and Alcohol-Related Health Outcomes (R01), to Describe Specific Interests of the National Cancer Institute
Long-acting Drug Delivery Systems for ART Optimization in HIV-1 Infected Children (R61/R33 Clinical Trial Not Allowed)
Eyes of CJD patients show evidence of prions
NIH statement on World COPD Day 2018
Reminder: Annual Reports to the Office of Laboratory Animal Welfare due January 31, 2019
Notice of a Pre-Application Webinar for RFA-CA-19-005 and RFA-CA-19-006 on Implementation Science for Cancer Control (Developing and Advanced Centers, respectively)
Notice of Availability of Administrative Supplements for Advancing Computational Modeling and Data Analytics Relevant to Mental Health
Request for Information (RFI): Soliciting Input on the Draft Strategic Plan for NIH Nutrition Research
Reinstatement of NIH SBIR Direct-to-Phase II Authority and Associated Updates to NINDS associated SBIR FOAs
Promoting Reductions in Intersectional StigMa (PRISM) to Improve the HIV Prevention Continuum (R01 Clinical Trial Optional)
Promoting Reductions in Intersectional StigMa (PRISM) to Improve the HIV Prevention Continuum (R34 Clinical Trial Required)
Promoting Reductions in Intersectional StigMa (PRISM) to Improve the HIV Prevention Continuum (R21 Clinical Trial Optional)
Accelerating Malaria Vaccine Discovery (R01 Clinical Trial Not Allowed)
Advancing Development of Rapid Fungal Diagnostics (R01 Clinical Trial Not Allowed)
Advancing Development of Rapid Fungal Diagnostics (R21 Clinical Trial Not Allowed)
Novel approaches to understand, prevent, treat, and diagnose coccidioidomycosis (Valley Fever) and other select endemic fungal infections (R21 Clinical Trial Not Allowed)
Novel approaches to understand, prevent, treat, and diagnose coccidioidomycosis (Valley Fever) and other select endemic fungal infections (R01 Clinical Trial Not Allowed)
Notice of Intent to Publish a Funding Opportunity Announcement for Diversity Program Consortium Sponsored Programs Administration Development (SPAD) Program (G11)
Support for Small Business Innovation Research to Develop New Open and Closed-Loop Automated Technologies for Better Type 1 Diabetes Therapy and Monitoring (SBIR) (R43/R44 Clinical Trial Not Allowed)
Specialized Centers of Research Excellence (SCORE) on Sex Differences (U54 Clinical Trial Optional)
Coming Soon: Grants Using Data Analytics to Support Chronic Disease Prevention and Management by Engaging Patient Navigators to Improve Population Health
Alzheimer's-focused administrative supplements for NIH grants that are not focused on Alzheimer's disease
Molecular and Genetic Characterization of Inborn Errors of Immunity (R01 Clinical Trial Not Allowed)
Molecular and Genetic Characterization of Inborn Errors of Immunity (R21 Clinical Trial Not Allowed)
Short Courses on Innovative Methodologies and Approaches in the Behavioral and Social Sciences (R25 Clinical Trial Not Allowed)
Enabling Technologies to Accelerate Development of Oral Biodevices (R43/R44 Clinical Trial Not Allowed)
Enabling Technologies to Accelerate Development of Oral Biodevices (R41/R42 Clinical Trial Not Allowed)
NIH researchers discover neural code that predicts behavior
Dr. Collins discusses the implications of the Human Genome Project on Bloomberg’s Prognosis podcast
Notice of Fiscal Policies in Effect for FY 2019
Ruth L. Kirschstein National Research Service Award (NRSA) Stipends, Tuition/Fees and Other Budgetary Levels Effective for Fiscal Year 2019
Notice of Intent to Publish a Funding Opportunity Announcement for HEAL Pain Effectiveness Research Network: Clinical Trial Planning and Implementation Cooperative Agreement (UG3/UH3 Clinical Trial Required)
Request for Information (RFI): Epidemiology of Opioid Use and Consequences- What is needed to understand and solve the crisis
Notice of NIDCD's Withdrawal from Participation in PA-19-055 "Research Project Grant (Parent R01 Clinical Trial Required)"
FY 2019 Fiscal Policies for Grant Awards: Funding Levels, Salary Limits, and Stipend Levels
Notice to Update Certificates of Confidentiality Terms and Conditions on all FDA Funding Opportunity Announcements and Grant Awards
Clinical trial of investigational Ebola treatments begins in the Democratic Republic of the Congo
Leveraging Health Information Technology (Health IT) to Address Minority Health and Health Disparities (R01 Clinical Trial Optional)
Findings of Research Misconduct
NIH Pathway to Independence Award (Parent K99/R00 Independent Basic Experimental Studies with Humans Required)
Mentored Quantitative Research Development Award (Parent K25 - Independent Basic Experimental Studies with Humans Required)
Mentored Research Scientist Development Award (Parent K01 - Independent Basic Experimental Studies with Humans Required)
Independent Scientist Award (Parent K02 - Independent Basic Experimental Studies with Humans Required)
NIH Research Project Grant (Parent R01 Basic Experimental Studies with Humans Required)
Mentored Patient-Oriented Research Career Development Award (Parent K23 Independent Basic Experimental Studies with Humans Required)
NIH Exploratory/Developmental Research Grant Program (Parent R21 Basic Experimental Studies with Humans Required)
Midcareer Investigator Award in Patient-Oriented Research (Parent K24 - Independent Basic Experimental Studies with Humans Required)
Mentored Clinical Scientist Research Career Development Award (Parent K08 - Independent Basic Experimental Studies with Humans Required)
New Funding Opportunities for Basic Experimental Studies Involving Humans
Alcohol-HIV/AIDS Program Project (P01 Clinical Trial Optional)
REMINDER - Expiring Funds Alert to AHRQ Grant Recipients who Received Multi-Year Funded Awards
Reminder to AHRQ Grantees that FY2014 Funds will Expire on September 30, 2019
NIH to evaluate effectiveness of male contraceptive skin gel
Statement on Claim of First Gene-Edited Babies by Chinese Researcher
In an opinion piece for USA Today, Drs. Collins and Gordon emphasize NIH’s commitment to suicide prevention research
Exploring Molecular Links Between Dietary Interventions and Circadian Rhythm (R01 Clinical Trial Not Allowed)
Research to Advance HBV Cure: HIV/HBV Co-Infection and HBV Mono-infection (R01 Clinical Trial Not Allowed)
FY 2019 Ruth L. Kirschstein National Research Service Award (NRSA) Stipends, Tuition/Fees, and Other Budgetary Levels
Notice of Extension of Expiration Date for PAR-16-070 NIDCR Small Research Grants for Data Analysis and Statistical Methodology Applied to Genome-wide Data (R03)
NHLBI Announces Plan to Fund a Limited MESA Exam 7
Notice to Specify High-Priority Research Topic for PAR-19-070
Notice to Specify High-Priority Research Topics for PAR-19-070 and PAR-19-071
Notice to Specify High-Priority Research Topic for PAR-19-070
Notice of NHLBI Participation in RFA-OD-19-012 "Short Courses on Innovative Methodologies and Approaches in the Behavioral and Social Sciences (R25 Clinical Trial Not Allowed)"
Emotion Regulation, Aging and Mental Disorder (R21 Clinical Trial Not Allowed)
Emotion Regulation, Aging and Mental Disorder (R01 Clinical Trial Not Allowed)
Control of Sexually Transmitted Infections (STIs) Through a Comprehensive Understanding of the Natural History of Infection (R01 Clinical Trial Not Allowed)
Notice to Specify High-Priority Research Topic for PAR-19-070
A Practice-Based Research Network to Transform Mental Health Care: Science, Service Delivery and Sustainability (U19 Clinical Trial Required)
Genetic Engineering Technologies for HIV Cure Research (U19 Clinical Trial Optional)
Experimental treatment for preeclampsia effective in animals, NIH-funded researchers show
Meeting the challenge of engaging men in HIV prevention and treatment
NIH Statement on World AIDS Day December 1, 2018
Notice of Change to Key Dates and Change to Matching Requirement Instructions for RFA-NS-19-010 "Optimization of Non-Addictive Therapies (Small Molecules and Biologics) to Treat Pain (UG3/UH3 Clinical Trial Not Allowed)"
Notice: Changes to the NIH Academic Research Enhancement Award (AREA)/R15 Program
Career Pathway to Independence in Blood Science Award for Physician Scientists (K99/R00 Independent Clinical Trial Not Allowed)
Career Pathway to Independence in Blood Science Award for Physician Scientists (K99/R00 Independent Clinical Trial Required)
Notice of Intent to Publish a Funding Opportunity Announcement for Career Pathway to Independence in Blood Science Award for Physician Scientists (R00 Clinical Trial Optional)
Changes to the R15 Academic Research Enhancement Award (AREA), and Introducing the R15 Research Enhancement Award Program (REAP)
ABCD study completes enrollment, announces opportunities for scientific engagement
New Financial Conflict of Interest Training Module Available
Detecting prions in eyes
Most ovarian cysts may not need surveillance
Probiotics not helpful for young children with diarrhea
U.S.-Brazil Collaborative Biomedical Research Program (R01 Clinical Trial Optional)
Addition of SBIR Direct-to-Phase II Application Type to NIAAA PA-18-578 "Investigational New Drug (IND)-enabling Development of Medications to Treat Alcohol Use disorder and Alcohol-related disorders (U44 - Clinical Trial Optional)"
Notice of Change in Award Budget for RFA-MH-19-411 "Promoting Reductions in Intersectional StigMa (PRISM) to Improve the HIV Prevention Continuum (R21 Clinical Trial Optional)
Notice to Specify High-Priority Research Topics for PAR-19-070
Notice of NIDCR Interest in Supporting Administrative Supplements for Collaborative Science
NIH researcher presents encouraging results for gene therapy for severe sickle cell disease
Ibrutinib plus rituximab superior to standard treatment for some patients with chronic leukemia
NIH-funded tissue chips rocket to International Space Station
Low-income, rural kids at higher risk for second- or third-hand smoke exposure
Elevated hormone flags liver problems in mice with methylmalonic acidemia
Request for Information (RFI): Input on Draft Report from Working Group on Reducing Administrative Burden to Researchers for Animal Care and Use in Research
Comments Welcomed on the Draft Report Recommending How to Reduce Administrative Burden in Research with Laboratory Animals: A Next Step in Implementing the 21st Century Cures Act
Notice of Intent to Publish Funding Opportunity Announcements for Research to Develop, Demonstrate, and Validate Experimental Human Tissue Models that Do Not Rely on Human Fetal Tissue
Moderate or severe sleep apnea doubles risk of hard-to-treat hypertension in African-Americans
HEAL Initiative: Back Pain Consortium (BACPAC) Research Program: Mechanistic Research Centers (U19 Clinical Trial Optional)
HEAL Initiative: Back Pain Consortium (BACPAC) Research Program: Phase 2 Clinical Trials (UG3/UH3 Clinical Trial Required)
HEAL Initiative: Back Pain Consortium (BACPAC) Research Program Data Integration, Algorithm Development and Operations Management Center (U24 Clinical Trial Not Allowed)
HEAL Initiative: Early Phase Pain Investigation Clinical Network - Data Coordinating Center (U24 Clinical Trials Not Allowed)
HEAL Initiative: Early Phase Pain Investigation Clinical Network - Clinical Coordinating Center (U24 Clinical Trial Not Allowed
HEAL Initiative: Early Phase Pain Investigation Clinical Network - Specialized Clinical Centers (U24 Clinical Trial Not Allowed)
HEAL Initiative: Translational Development of Devices to Treat Pain (U18 Clinical Trial Not Allowed)
HEAL Initiative: Translational Devices to Treat Pain (U44 Clinical Trial Optional)
HEAL Initiative: Clinical Devices to Treat Pain (UH3 Clinical Trial Optional)
HEAL Initiative: Antenatal Opioid Exposure Longitudinal Study Consortium (PL1 Clinical Trials Not Allowed)
HEAL Initiative Limited Competition: Behavioral Research to Improve MAT: Ancillary Studies to Enhance Behavioral or Social Interventions to Improve Adherence to Medication Assisted Treatment for Opioid Use Disorders (R01, Clinical Trials Optional)
Heal Initiative: Pragmatic Randomized Controlled Trial of Acupuncture for Management of Chronic Low Back Pain in Older Adults (UG3/UH3 Clinical Trial Required)
HEAL Initiative: Americas Startups and Small Businesses Build Technologies to Stop the Opioid Epidemic (R41/R42 - Clinical Trial Optional)
HEAL Initiative: Americas Startups and Small Businesses Build Technologies to Stop the Opioid Epidemic (R43/R44 - Clinical Trial Optional)
HEAL Initiative: Request for Administrative Supplements to Existing Grants to Accelerate Research on Preventing Opioid Use Disorder in Older Adolescents and Young Adults (ages 1630)
HEAL Initiative: Notice of Interest in Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) Applications Directed at Enhanced Pain Management and Improved Treatments for Opioid Misuse and Addiction
HEAL Initiative: Pragmatic and Implementation Studies for the Management of Pain to Reduce Opioid Prescribing (PRISM) (UG3/UH3, Clinical Trials Optional)
HEAL Initiative: Sleep and Circadian-Dependent Mechanisms Contributing to Opiate Use Disorder (OUD) and Response to Medication Assisted Treatment (MAT) (U01 Clinical Trial Optional)
HEAL Initiative: Justice Community Opioid Innovation Network (JCOIN) Methodology and Advanced Analytics Resource Center (U2C Clinical Trial Not Allowed)
HEAL Initiative: Justice Community Opioid Innovation Network (JCOIN) Coordination and Translation Center (U2C Clinical Trial Optional)
HEAL Initiative: Justice Community Opioid Innovation Network (JCOIN) Clinical Research Centers (UG1 Clinical Trial Optional)
HEAL Initiative: Integrated Approach to Pain and Opioid Use in Hemodialysis Patients: The Hemodialysis Opioid Prescription Effort (HOPE) Consortium - Scientific and Data Research Center (U01 Clinical Trial Required)
HEAL Initiative: Integrated Approach to Pain and Opioid Use in Hemodialysis Patients: The Hemodialysis Opioid Prescription Effort (HOPE) Consortium - Clinical Centers (U01 Clinical Trial Required)
HEAL Initiative: Announcement of the NCATS ASPIRE Design Challenges to Develop Innovative and Catalytic Approaches Towards Solving the Opioid Crisis
HEAL Initiative: Sleep and Circadian-Dependent Mechanisms Contributing to Opiate Use Disorder (OUD) and Response to Medication Assisted Treatment (MAT) (R01 - Clinical Trial Not Allowed)
HEAL Initiative: Behavioral Research to Improve MAT: Behavioral and Social Interventions to Improve Adherence to Medication Assisted Treatment for Opioid Use Disorders (R61/R33 Clinical Trial Optional)
HEAL Initiative: Coordinating Center to Support NIDA Preventing Opioid Use Disorder in Older Adolescents and Young Adults (ages 1630) Initiative (U24 Clinical Trial Not Allowed)
HEAL Initiative: Translational Devices to Treat Pain (UG3/UH3 Clinical Trial Optional)
HEAL Initiative: Back Pain Consortium (BACPAC) Research Program Technology Research Sites (UH2/UH3 Clinical Trial Optional)
HEAL Initiative: Effectiveness Trials to Optimize, Implement, Scale, and Sustain the Collaborative Care Model for Individuals with Opioid Use Disorders and Mental Health Conditions (U01 Clinical Trial Required)
HEAL Initiative: Optimization of Non-addictive Therapies [Small Molecules and Biologics] to Treat Pain - (U44 Clinical Trial Not Allowed)
HEAL Initiative: Tissue Chips to Model Nociception, Addiction, and Overdose (UG3/UH3 Clinical Trial Not Allowed)
HEAL Initiative: Biofabricated 3D Tissue Models of Nociception, Opioid Use Disorder and Overdose for Drug Screening (UH2/UH3 Clinical Trial Not Allowed)
HEAL Initiative: Stimulating Peripheral Activity to Relieve Conditions (SPARC): Anatomical and Functional Mapping of Pain-Related Visceral Organ Neural Circuitry (U01 Clinical Trial Optional)
HEAL Initiative: Pain Management Effectiveness Research Network: Clinical Trial Planning and Implementation Cooperative Agreement (UG3/UH3 Clinical Trial Required)
HEAL Initiative: Preventing Opioid Use Disorder in Older Adolescents and Young Adults (ages 1630) (UG3/UH3 Clinical Trial Required)
NIH needs your innovative research ideas through our newly announced NIH HEAL Initiative funding opportunities
Study links frequent red meat consumption to high levels of chemical associated with heart disease
Notice of Change to PAR-18-319 "HIV Vaccine Research and Design (HIVRAD) Program (P01 Clinical Trial Not Allowed)"
Findings of Research Misconduct
Notice of Interest in Long-term Maintenance of Behavior Change Research
Notice of Information: NIMH Priorities for Research to Inform Stepped-Care Interventions for Persons at Clinical High Risk for Psychosis
Comprehensive Alcohol-HIV/AIDS Research Center (P60 Clinical Trial Optional)
Notice of Changes in the Eligibility of Candidates and Budget Supported by the NIMH Administrative Supplement Program to Enable Continuity of Research Experiences of MD/PhDs during Clinical training (Admin Supp)
NHLBI Announces Plan to Fund a Limited MESA Exam 7
Notice of NIBIB's Participation in PA-18-817 "Administrative Supplements for Research on Dietary Supplements (Admin Supp - Clinical Trial Not Allowed)"
NHLBI Announces Participation in RFA-OD-19-013 "Specialized Centers of Research Excellence (SCORE) on Sex Differences (U54 Clinical Trial Optional)"
Emerging Global Leader Award (K43 Independent Clinical Trial Not Allowed)
Center without Walls for PET Ligand Development for Alzheimer's disease related dementias (ADRDs) (U19 Clinical Trial Optional)
NIH to fund HIV care and prevention research in vulnerable southern U.S. communities
NHLBI Accepts Only Investigator-Initiated Clinical Trial Applications Proposing Mechanistic Studies and Basic Experimental Studies Involving Humans (BESH) in Response to the NIH Parent R01 Clinical Trial Required Announcement
NHLBI accepts investigator-initiated basic experimental studies involving humans (BESH) that meet NIHs definition of a clinical trial only in response to PA-18-345 NIH Research Project Grant (Parent R01 Clinical Trial Required)
Reinstatement of NIH SBIR Direct-to-Phase II Authority and Associated Updates to PA-18-705
Notice of Intent to Publish a Funding Opportunity Announcement for Administrative Supplements for Research on Bioethical Issues
Researchers design technology that sees nerve cells fire
Physical Sciences-Oncology Network (PS-ON): Physical Sciences-Oncology Projects (PS-OP) (U01 Clinical Trial Optional)
Graduate Research Training Initiative for Student Enhancement (G-RISE) (T32)
Limited Competition: Clinical and Translational Science Award (CTSA) Program: Collaborative Innovation Award, (U01 Clinical Trial Optional)
Limited Competition: Clinical and Translational Science Award (CTSA) Program: Exploratory Collaborative Innovation Awards (R21 Clinical Trial Optional)
NIDCR Mentoring Network to Support a Diverse Dental, Oral and Craniofacial Research Workforce (UE5 Clinical Trials Not Allowed)
Advance Notice: Streamlining the Certifications and Representations Process and Phasing out the SF-424B
Notice of Expiration of PA-18-471 "Innovative Questions in Symptom Science and Genomics (R15 Clinical Trial Not Allowed)"
Notice of Expiration of PA-18-475 " Community Partnerships to Advance Research (CPAR) (R15 Clinical Trial Not Allowed)"
Notice of NIBIB's Participation in PAR-19-093 "Leveraging Health Information Technology (Health IT) to Address Minority Health and Health Disparities (R01 Clinical Trial Optional)"
Don’t Wait to Spring Into Action: Early Registration Rates End Soon for Spring 2019 NIH Regional Seminar
Can My Application be Considered a Resubmission Even if I am Not Re-Submitting to the Same FOA?
Always Check Your FOA for New Related Notices 30 Days Before Submission
Notice of Change to Requirement for Letter of Support from the Applicant Institution's Authorized Organizational Representative in PAR-17-094 "Maximizing Investigators' Research Award (R35)"
Notice of Pre-Application Webinars for the HEAL Initiative: Back Pain Consortium (BACPAC) Research Program
Notice of NINDS' Participation in NOT-AG-18-050 "Notice to Specify High-Priority Research Topic for PAR-19-070"
Resources for Rigorous Research
Notice of Additional Funds Available for PAS-18-625, " Mechanistic investigations of psychosocial stress effects on opioid use patterns (R21- Clinical Trial Optional)"
Contraception Research Centers Program (U54 Clinical Trial Optional)
Discovery of the Genetic Basis of Childhood Cancers and of Structural Birth Defects: Gabriella Miller Kids First Pediatric Research Program (X01 Clinical Trial Not Allowed)
NIH scientists find that breast cancer protection from pregnancy starts decades later
NIH Research Evaluation and Commercialization Hubs (REACH) Awards (U01 Clinical Trial Not Allowed)
Notice of Expiration for PA-18-495 Academic Research Enhancement Award in Diseases within the Mission of NIDDK (R15 Clinical Trial Required)
Notice of Additional Funds Available for PAS-18-624, " Mechanistic investigations of psychosocial stress effects on opioid use patterns (R01- Clinical Trial Optional)"
AHRQ Notice of Cancellation of PA 17-260 and PA 17-261
Notice of Change in the Award Project Period section in PA-18-914, "Supplements to Advance Research (STAR) from Projects to Programs"
Human Islet Research Network - Consortium on Modeling Autoimmune Interactions (HIRN-CMAI) (U01 Clinical Trial Not Allowed)
Stimulating Hematology Investigation: New Endeavors (SHINE) (R01 Clinical Trial Not Allowed)
Cancer Tissue Engineering Collaborative: Enabling Biomimetic Tissue-Engineered Technologies for Cancer Research (R01 Clinical Trial Optional)
Improving Outcomes in Cancer Treatment-Related Cardiotoxicity (R21 Clinical Trial Optional)
Improving Outcomes in Cancer Treatment-Related Cardiotoxicity (R01 Clinical Trial Optional)
Notice of Change in Expiration Date of PA-17-278 "HIV and Hepatitis B Co-Infection: Advancing HBV Functional Cure through Clinical Research (R21)"
Notice to Specify High-Priority Research Topic for PAR-19-070 and PAR-19-071
Teens using vaping devices in record numbers
2018 Research Highlights — Clinical Advances
2018 Research Highlights — Insights From the Lab
2018 Research Highlights — Promising Medical Advances
Notice of Change in Key Dates for RFA-ES-18-009 "Maintain and Enrich Resource Infrastructure for Existing Environmental Epidemiology Cohorts (R24 Clinical Trial Not Allowed)"
NIDDK Will Participate in RFA-OD-19-012: Short Courses on Innovative Methodologies and Approaches in the Behavioral and Social Sciences (R25 Clinical Trial Not Allowed)
Notice of Change in Expiration Date of PA-17-280 "In Vitro and Animal Model Studies on HBV/HIV Co-Infection (R01)"
Non-human Primates Facilities to Support HIV/AIDS-related Research (C06 Clinical Trial Not Allowed)
Notice of PA 15-179 and PA 16-420 Cancellation
NCCIH Only Accepts Clinical Trial Applications Proposing Mechanistic Studies for Clinical Trial Parent R01 Announcements
Notice of PA Cancellation: PA-15-180
Notice of Change to FOA (RFA-OD-19-013) "Specialized Centers of Research Excellence (SCORE) on Sex Differences (U54 Clinical Trial Optional)"
Limited Competition: NeuroImaging Tools and Resources Collaboratory (R24 Clinical Trial Not Allowed)
Pelvic floor disorders linked to mode of delivery among first-time mothers
Revision Application for Implementation Research to Inform and Enhance PEPFAR HIV Pre-exposure Prophylaxis (PrEP) Delivery (R01 Clinical Trial Optional)
2,000 human brains yield clues to how genes raise risk for mental illnesses
Notice to Announce Webinar to Request Public Input on Upcoming Surgeon Generals Report on Oral Health
Notice of NCI Participation in RFA-AI-18-054, U.S.-Brazil Collaborative Biomedical Research Program (R01 Clinical Trial Optional)
Notice of Change in Expiration Date of PA-17-281 "In Vitro and Animal Model Studies on HBV/HIV Co-Infection (R21)"
Notice of Intent to Publish a Funding Opportunity Announcement for the Maximizing Investigators' Research Award Program
Notice of Changes to PA-19-082, "Novel approaches to understand, prevent, treat, and diagnose coccidioidomycosis (Valley Fever) and other select endemic fungal infections (R01 Clinical Trial Not Allowed)"
Notice of Changes to PA-19-083, "Novel approaches to understand, prevent, treat, and diagnose coccidioidomycosis (Valley Fever) and other select endemic fungal infections (R21 Clinical Trial Not Allowed)"
Notice of NCI Participation in PAR-19-064, Mechanism for Time-Sensitive Drug Abuse Research (R21 Clinical Trial Optional)
Notice of Change to Key Dates and Peer Review Contact for RFA-DK-18-001, Silvio O. Conte Digestive Diseases Research Core Centers (P30 Clinical Trial Optional)
Notice to update Application Types Allowed for PAR-18-763 "Innovation Grants to Nurture Initial Translational Efforts (IGNITE): Development and Validation of Model Systems and/or Pharmacodynamic Markers to Facilitate Neurotherapeutic Discovery (R61/R33)
Notice of NEI's participation in PAR-18-714, "Academic Research Enhancement Award for Undergraduate-Focused Institutions (R15 - Clinical Trial Not Allowed)"
Notice of Change to PAR-18-940 Clinical and Translational Science Award (U54 Clinical Trial Optional)
Notice of Correction to Application Types Allowed for RFA-DA-19-019, "HEAL Initiative: Americas Startups and Small Businesses Build Technologies to Stop the Opioid Crisis (R43/R44 - Clinical Trial Optional)"
Notice of Pre-Application Information Webinar and Frequently Asked Questions (FAQs) for RFA-DA-19-025, RFA-DA-19-024, RFA-DA-19-023, " HEAL Initiative: Justice Community Opioid Innovation Network (JCOIN) "
Notice to Encourage Eligible NHGRI Awardees to Apply for PA-18-906 "Research Supplements to Promote Diversity in Health-Related Research
Midcareer Investigator Award in Patient-Oriented Research (Parent K24 Independent Clinical Trial Required)
Midcareer Investigator Award in Patient-Oriented Research (Parent K24 Independent Clinical Trial Not Allowed)
Mentored Research Scientist Development Award (Parent K01 - Independent Clinical Trial Not Allowed)
Mentored Research Scientist Development Award (Parent K01 - Independent Clinical Trial Required)
Notice of NIMHD Interest in Receiving Letters Requesting Permission to Submit Applications to Support a Research Centers in Minority Institutions (RCMI) Program National Conference (U13)
Independent Scientist Award (Parent K02 - Independent Clinical Trial Required)
Independent Scientist Award (Parent K02 - Independent Clinical Trial Not Allowed)
NIH Pathway to Independence Award (Parent K99/R00 - Independent Clinical Trial Required)
NIH Pathway to Independence Award (Parent K99/R00 - Independent Clinical Trial Not Allowed)
NEI Audacious Goals Initiative: Preliminary Studies for Translation-Enabling Models of the Visual System (R21 Clinical Trial Not Allowed)
Notice of Intent to Publish Funding Opportunity Announcements for the Intellectual and Developmental Disabilities Research Centers (IDDRC) (PM1 Clinical Trial Optional)
Notice of Correction to Advisory Council Review Dates for PAR-19-070 and PAR-19-071, "Research on Current Topics in Alzheimer's Disease and Its Related Dementias"
Notice of NLM's Participation in PAR-19-093 "Leveraging Health Information Technology (Health IT) to Address Minority Health and Health Disparities (R01 Clinical Trial Optional)"
Clarification of the Award Period for NOT-AG-18-039, "Alzheimer's-focused administrative supplements for NIH grants that are not focused on Alzheimer's disease"
Biomedical Research Facilities (C06 Clinical Trial Not Allowed)
Notice of Interest in Advancing Research in Acute Flaccid Myelitis and Guillain-Barre Syndrome
Mentored Clinical Scientist Research Career Development Award (Parent K08 Independent Clinical Trial Not Allowed)
Mentored Clinical Scientist Research Career Development Award (Parent K08 Independent Clinical Trial Required)
Notice of Intent to Publish a Funding Opportunity Announcement for Antenatal Opioid Exposure Longitudinal Study Consortium (PL1 Clinical Trials Not Allowed)
Mentored Patient-Oriented Research Career Development Award (Parent K23 Independent Clinical Trial Required)
Mentored Patient-Oriented Research Career Development Award (Parent K23 Independent Clinical Trial Not Allowed)
Notice of Change in Expiration Date of PA-17-279 "HIV and Hepatitis B Co-Infection: Advancing HBV Functional Cure through Clinical Research (R01)"
Notice of Consolidation and Additional Clarifications of Applications Relevant to PAR-17-046 "Exploratory Research for Technology Development (R21)"
NCI Pathway to Independence Award for Outstanding Early Stage Postdoctoral Researchers (K99/R00 - Independent Clinical Trial Required)
NCI Pathway to Independence Award for Outstanding Early Stage Postdoctoral Researchers (K99/R00 - Independent Clinical Trial Not Allowed)
Notice of Change to Requirement for Letter of Support from the Applicant Institution's Authorized Organizational Representative in PAR-17-190 "Maximizing Investigators' Research Award for Early Stage Investigators (R35)"
Mentored Quantitative Research Development Award (Parent K25 - Independent Clinical Trial Required)
Mentored Quantitative Research Development Award (Parent K25 - Independent Clinical Trial Not Allowed)
Updates for RFA-MH-19-225, A Practice-Based Research Network to Transform Mental Health Care: Science, Service Delivery and Sustainability (U19 Clinical Trial Required)
Notice of NIMH Participation in PAR-18-714 " Academic Research Enhancement Award for Undergraduate-Focused Institutions (R15 - Clinical Trial Not Allowed)
Notice of Clarification of Institutional Eligibility for PAR-19-037 "Initiative for Maximizing Student Development (IMSD) (T32)"
Study finds elevated risk of certain rare blood cancers after chemotherapy for most solid tumors
NIH-developed test detects protein associated with Alzheimer’s and CTE
New pathways for implementing universal suicide risk screening in healthcare settings
Mourning the Loss of NIAMS Director Stephen Katz, M.D., Ph.D.
HEAL Initiative: HEALthy Brain and Child Development Study (HEALthy BCD) ( R34- Clinical Trial Not Allowed)
HEAL Initiative: HEALthy Brain and Child Development Study (HEALthy BCD) (Collaborative R34- Clinical Trial Not Allowed)
NIMH Acceptance of Clinical Trial Applications under the Parent R01 and R21 Clinical Trial Required, or Basic Experimental Studies Involving Humans (BESH) Announcements is Limited to Mechanistic Clinical Trials
Laboratories for Early Clinical Evaluation of Pharmacotherapies for Substance Use Disorders (UG1 Clinical Trial Required)
Academic Research Enhancement Award for Undergraduate-Focused Institutions (R15 - Clinical Trial Required)
End-of-Life and Palliative Needs of Adolescents and Young Adults (AYA) with Serious Illnesses (R01 Clinical Trial Optional)
Research Enhancement Award Program (REAP) for Health Professional Schools and Graduate Schools (R15 Clinical Trial Not Allowed)
Research Enhancement Award Program (REAP) for Health Professional Schools and Graduate Schools (R15 Clinical Trial Required)
Notice of NHLBI Participation in PAR-19-135 "Research Enhancement Award Program (REAP) for Health Professional Schools and Graduate Schools (R15 Clinical Trial Required)"
NIDCD Clinical Research Center Grant (P50 Clinical Trial Optional)
Resources for Technology Dissemination (U24 Clinical Trial Not Allowed)
ImmuneChip: Engineering Microphysiological Immune Tissue Platforms (U01 Clinical Trial Not Allowed)
Better mouse model built to enable precision-medicine research for Alzheimer's
NIDCD Research Career Enhancement Award for Established Investigators (K18 Basic Experimental Studies with Humans Required)
NIDCR Dual Degree Dentist Scientist Pathway to Independence Award (K99/R00 Independent Clinical Trial Not Allowed)
NIDCR Dual Degree Dentist Scientist Pathway to Independence Award (K99/R00 Independent Basic Experimental Studies with Humans Required)
NIDCD Mentored Career Development Award for Postdoctorate Au.D./Ph.D. Audiologists (K01 Independent Basic Experimental Studies with Humans Required)
Notice of Change to Key Dates for RFA-NS-19-021 "HEAL Initiative: Pain Management Effectiveness Research Network: Clinical Trial Planning and Implementation Cooperative Agreement (UG3/UH3 Clinical Trial Required)"
NCCIH Policy for SBIR and STTR Phase I Applications Proposing Clinical Trials to the Omnibus Solicitations
Request for Information (RFI): NICHD Strategic Plan Fiscal Years 2020-2024
Analytical Tools and Approaches for (Multidimensional) Scholarly Research Assessment and Decision Support in the Biomedical Enterprise (R43/R44 - Clinical Trial Not Allowed)
Analytical Tools and Approaches for (Multidimensional) Scholarly Research Assessment and Decision Support in the Biomedical Enterprise (R41/R42 - Clinical Trial Not Allowed)
NIH Implementation of the Final Rule on the Federal Policy for the Protection of Human Subjects (Common Rule)
Notice to Specify High-Priority Research Topic for PAR-19-070 and PAR-19-071
U.S.-China Program for Biomedical Collaborative Research (R01 Clinical Trial Optional)
Notice to Specify High-Priority Research Topic for PAR-19-070 and PAR-19-071
Proximity to muscle cells may promote spread of prostate cancer cells, NIH study suggests
NIH study implicates hyperactive immune system in aging brain disorders
Notice of Intent to Publish a Funding Opportunity Announcement for INCLUDE (INvestigation of Co-occurring conditions across the Lifespan to Understand Down syndromE) Project
Notice of Intent to Publish: Cellular Cancer Biology Imaging Research (CCBIR) Program (UM1 Clinical Trial Not Allowed)
Exploring the Mechanisms Underlying Analgesic Properties of Minor Cannabinoids and Terpenes (R01 Clinical Trial Optional)
Exploring the Mechanisms Underlying Analgesic Properties of Minor Cannabinoids and Terpenes (R21 Clinical Trial Optional)
Dr. Collins and soprano Renée Fleming discuss the intersection between music and health with Folks Magazine
Notice of NIMHD Participation in PA-19-118, Mentored Patient-Oriented Research Career Development Award (Parent K23 Independent Clinical Trial Required)"
Notice of NIMHD Participation in PA-19-119, "Mentored Patient-Oriented Research Career Development Award (Parent K23 Independent Clinical Trial Not Allowed)"
Notice of NIMHD Participation in PA-19-129, "NIH Pathway to Independence Award (Parent K99/R00 - Independent Clinical Trial Required)"
Notice of Expiration of PA-18-635 "NEI Academic Research Enhancement Award for Mechanistic and Minimal Risk Human Subjects' Research (R15 Clinical Trial Optional)"
Notice of Correction to Application Types Allowed for RFA-DA-19-030, " Analytical Tools and Approaches for (Multidimensional) Scholarly Research Assessment and Decision Support in the Biomedical Enterprise (R41/R42 - Clinical Trial Not Allowed)"
Notice of NIMHD Participation in PA-19-127, "Mentored Research Scientist Development Award (Parent K01 - Independent Clinical Trial Required)"
Findings of Research Misconduct
Findings of Research Misconduct
Notice of 3 Pre-Application Webinars for NCCIH HEAL Funding Opportunity Announcements
Notice of Pre-Application Webinar Part II for RFA-AG-19-025 and RFA-AG-19-026, "Development of Personalized In Vitro Assays to Quantitatively Assess Age-related Changes in Cellular Resiliencies to Physiologic Stressors (SBIR/STTR)"
Request for Proposals (RFP) Notice: Quantification of Drugs of Abuse and Related Substances in Biological Specimens
Notice of NIMHD Participation in PA-19-126, "Mentored Research Scientist Development Award (Parent K01 - Independent Clinical Trial Not Allowed)"
Notice of NIMHD Participation in PAR-19-134 "Research Enhancement Award Program (REAP) for Health Professional Schools and Graduate Schools (R15 Clinical Trial Not Allowed)"
Notice of NIMHD Participation in PAR-19-135 "Research Enhancement Award Program (REAP) for Health Professional Schools and Graduate Schools (R15 Clinical Trial Required)"
Notice of Changes to Award Information for RFA-AG-19-025 "Development of Personalized In Vitro Assays to Quantitatively Assess Age-related Changes in Cellular Resiliencies to Physiologic Stressors (R43/R44 Clinical Trial Not Allowed)"
Notice of Changes to Award Information for RFA-AG-19-026 "Development of Personalized In Vitro Assays to Quantitatively Assess Age-related Changes in Cellular Resiliencies to Physiologic Stressors (R41/R42 Clinical Trial Not Allowed)"
Notice of NIMHD Participation in PA-19-116, "Mentored Clinical Scientist Research Career Development Award (Parent K08 Independent Clinical Trial Required)"
Notice of NIMHD Participation in PA-19-117, "Mentored Clinical Scientist Research Career Development Award (Parent K08 Independent Clinical Trial Not Allowed)"
Notice of NIMHD Participation in PA-19-130, "NIH Pathway to Independence Award (Parent K99/R00 - Independent Clinical Trial Not Allowed)"
Notice of Pre-Application Webinar for RFA-DE-19-007 "NIDCR Mentoring Network to Support a Diverse Dental, Oral and Craniofacial Research Workforce (UE5 Clinical Trial Not Allowed)"
Revisions for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (U2C Clinical Trial Optional)
Revisions for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (U54 Clinical Trials Optional)
Revisions for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (P50 Clinical Trial Optional)
Revisions for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (R01 Clinical Trial Optional)
Revisions for Incorporation of Novel NCI- Supported Technology to Accelerate Cancer Research (U01 Clinical Trial Optional)
Revisions for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (P01 Clinical Trial Optional)
Notice to Extend the Expiration Date for PAR-18-102: Small Grants for New Investigators to Promote Diversity in Health-Related Research (R21 Clinical Trial Optional)
Notice of Special Interest in Understanding Factors in Infancy and Early Childhood (Birth to 24 months) That Influence Obesity Development
Notice of Intent to Publish a Funding Opportunity Announcement for Biological Measures for Prognosing and Monitoring of Persistent Concussive Symptoms in Early and Middle Adolescents: Center Without Walls (CWOW) (U54 Clinical Trial Optional)
Notice of NIDCR Participation in RFA-DA-19-035 "HEAL Initiative: Preventing Opioid Use Disorder in Older Adolescents and Young Adults (ages 1630) (UG3/UH3 Clinical Trial Required)"
Notice of Correction to Award Budget for PA-18-916 AIDS-Science Track Award for Research Transition (R03 Clinical Trial Optional)
Advanced Development and Validation of Emerging Biospecimen Science Technologies for Basic and Clinical Cancer Research (R33 Clinical Trials Not Allowed)
Innovative Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research (R21 Clinical Trials Not Allowed)
Advanced Development and Validation of Emerging Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research (R33 Clinical Trials Not Allowed)
Innovative Biospecimen Science Technologies for Basic and Clinical Cancer Research (R21 Clinical Trials Not Allowed)
Notice of Pre-Application Information Webinar and Frequently Asked Questions (FAQs) for HEAL Initiatives RFA-DA-19-035 (UG3/UH3) and RFA-DA-19-034 (U24): Preventing Opioid Use Disorder in Older Adolescents and Young Adults (ages 16-30) Initiative "
Notice of Availability of Administrative Supplements for Equipment Purchases for NIGMS Awardees
NIH Operational During Partial Federal Government Shutdown
PRE-APPLICATION PAR-19-128 BIOMEDICAL RESEARCH FACILITIES (C06) WEBINAR
Notice of New Application Instructions for Classifying Training Program Area in PAR-17-341 "National Institute of General Medical Sciences Ruth L. Kirschstein National Research Service Award (NRSA) Predoctoral Institutional Research Training Grant (T32)"
NIH Policy for Review and Resubmission of New Investigator R01 Applications
January 21 (Monday), 2019: NIH Closed For the Federal Holiday
How Do I Determine if My Institution is Eligible For an R15 Research Enhancement Award?
NIH Implementation of the Final Rule on the Federal Policy for the Protection of Human Subjects (Common Rule)
Revealing gene regulation in the brain
Genetically modified houseplant cleans indoor air
Eating red meat daily triples heart disease-related chemical
Request for Information (RFI): Inviting Comments on the NIDA Strategic plan for Research at the Intersection of HIV/AIDS and Substance Use, Misuse and Addiction
New Resources Available for Basic Experimental Studies with Humans (BESH) Funding Opportunities
Is My Ancillary Study Considered a Clinical Trial?
NHLBI Clinical Trial Pilot Studies (R34 Clinical Trial Optional)
NIDCR Small Research Grants for Oral Health Data Analysis and Statistical Methodology Development (R03 Clinical Trial Not Allowed)
Drug Discovery For Nervous System Disorders (R01 Clinical Trials Not Allowed)
Drug Discovery For Nervous System Disorders (R21 Clinical Trial Not Allowed)
Bioengineering Research Grants (BRG) (R01 Clinical Trial Required)
Bioengineering Research Grants (BRG) (R01 Clinical Trial Not Allowed)
Exploratory/Developmental Bioengineering Research Grants (EBRG) (R21 Clinical Trial Optional)
Exploratory/Developmental Bioengineering Research Grants (EBRG) (R21 Clinical Trial Not Allowed)
Bioengineering Research Partnerships (U01 Clinical Trial Required)
Bioengineering Research Partnerships (U01 Clinical Trial Not Allowed)
End-of-Life and Palliative Needs of Adolescents and Young Adults (AYA) with Serious Illnesses (R21 Clinical Trial Optional)
Reminder of Policy Changes
Notice of NIAMS Participation in "Exploratory/Developmental Bioengineering Research Grants (EBRG) (R21 Clinical Trial Not Allowed)"
NIDCR Dentist Scientist Career Transition Award for Intramural Investigators (K22 Independent Basic Experimental Studies with Humans Required)
NIDCR Dentist Scientist Career Transition Award for Intramural Investigators (K22 Independent Clinical Trial Not Allowed)
NIDCR Mentored Career Development Award to Promote Diversity in the Dental, Oral and Craniofacial Workforce (K01 Independent Basic Experimental Studies with Humans Required)
NIDCR Mentored Career Development Award to Promote Diversity in the Dental, Oral and Craniofacial Workforce (K01 Independent Clinical Trial Not Allowed)
Notice of NIMHD's Interest in Research on Disability in Health Disparity Populations
Notice of NIAID's Participation in PAR-19-158 "Bioengineering Research Grants (BRG) (R01 Clinical Trial Not Allowed)"
Notice of NIMHD Participation in RFA-DA-19-034, "HEAL Initiative: Coordinating Center to Support NIDA Preventing Opioid Use Disorder in Older Adolescents and Young Adults (ages 1630) Initiative (U24 Clinical Trial Not Allowed)
Notice of NIMHD Participation in RFA-DA-19-035, "HEAL Initiative: Preventing Opioid Use Disorder in Older Adolescents and Young Adults (ages 1630) (UG3/UH3 Clinical Trial Required)"
Mobile Technologies Extending Reach of Primary Care for Substance-Use-Disorders (R43/R44 Clinical Trial Optional)
Mobile Technologies Extending Reach of Primary Care for Substance-Use-Disorders (R41/R42 Clinical Trial Optional)
Notice of Clarification Regarding Harassment and Discrimination Protections in NIH Training Applications
Notice of Information: Updates and clarifications of several components of the Challenge competition posted within the Federal Register
Accelerating the Pace of Child Health Research Using Existing Data from the Adolescent Brain Cognitive Development (ABCD) Study (R21-Clinical Trial Not Allowed)
Accelerating the Pace of Child Health Research Using Existing Data from the Adolescent Brain Cognitive Development (ABCD) Study (R01-Clinical Trial Not Allowed)
The Human Biomolecular Atlas Program (HuBMAP): Rapid Implementation of Technologies that Will Accelerate Development of a Framework for Mapping the Human Body at High Resolution (UH3 Clinical Trial Not Allowed)
BRCA Exchange aggregates data on thousands of BRCA variants to inform understanding of cancer risk
The Experimental Therapeutics Clinical Trials Network (ETCTN) Pharmacokinetic Resource Laboratories (U24 Clinical Trials Not Allowed)
The Experimental Therapeutics Clinical Trials Network (UM1 Clinical Trials Required)
Notice of Intent to Publish Funding Opportunity Announcements for Phase 2 of the U.S.-South Africa Program for Collaborative Biomedical Research (R01 and U01, Clinical Trial Optional)
Notice of Added Receipt Dates and Later Expiration Date for PA-19-029, Innovation Corps (I-Corps) at NIH Program for NIH and CDC Translational Research (Admin Supp Clinical Trial Not Allowed)
Extension of Comment Period on Draft Report: Reducing Administrative Burden to Researchers for Animal Care and Use in Research
Type 1 Diabetes TrialNet Clinical Network Hub (U01 Clinical Trial Not Allowed)
Limited Competition for the Continuation of the Coordinating Center for Type 1 Diabetes TrialNet (U01 Clinical Trial Required)
Notice of Expiration for PA-18-627 NIDA Academic Research Enhancement Award (R15 Clinical Trial Required)
Notice to Expire PA-18-343 'Academic Research Enhancement Award (R15 Clinical Trial Required)'
Administrative Supplements to NIGMS Predoctoral Training Grants for Development of Curricular or Training Activities to Enhance Predoctoral Training
AI approach outperformed human experts in identifying cervical precancer
The science is clear: with HIV, undetectable equals untransmittable
Improving Outcomes for Pediatric, Adolescent and Young Adult Cancer Survivors (U01 Clinical Trial Required)
Pre-Application Webinar for RFA-CA-19-033, Improving Outcomes for Pediatric, Adolescent and Young Adult Cancer Survivors (U01 Clinical Trial Required)
Virtual Reality Tools to Enhance Evidence Based Treatment of Substance Use Disorders (R41/R42 - Clinical Trial Optional)
Virtual Reality Tools to Enhance Evidence Based Treatment of Substance Use Disorders (R43/R44 - Clinical Trial Optional)
AHRQ Implementation of Final Rule on the Federal Policy for the Protection of Human Subjects (Common Rule)
Summer Research Education Experience Program (Clinical Trials Not Allowed R25)
Notice of NIBIB's Participation in PAR-19-164 "Summer Research Education Experience Program (Clinical Trials Not Allowed R25)"
Notice of Correction to Application Form Instructions for PAR-18-829, "NCCIH Natural Product Early Phase Clinical Trial Phased Innovation Award (R61/R33 Clinical Trial Required)"
Removal of the Requirement for Institutional Review Board Review of NIH Grant Applications and Contract Proposals Related to Research
Notice of Updated Application Forms Package for PAR-18-828, "NCCIH Natural Product Early Phase Clinical Trial Award (R33 Clinical Trial Required)"
Notice of Participation of the National Institute on Minority Health and Health Disparities (NIMHD) in PAR-19-070, Research on Current Topics in Alzheimers Disease and its Related Dementias (R01 Clinical Trial Optional)
Notice of Participation of the National Institute on Minority Health and Health Disparities (NIMHD) in PAR-19-071, Research on Current Topics in Alzheimers Disease and its Related Dementias (R21 Clinical Trial Not Allowed)
Notice of Letter of Intent Guidance for PAR-19-098 Emerging Global Leader Award (K43; Independent Clinical Trial Not Allowed) and PAR-19-051 Emerging Global Leader Award (K43; Independent Clinical Trial Required)
Register to Attend the NIH Regional Seminar on Program Funding and Grants Administration Baltimore, MD May 2019
AHRQ Announces Change in Grant Recipient Purchasing of Identifiable CMS Data, effective FY2019
Notice of Change in the NEI K23 Eligibility Requirements
Request for Information (RFI): Input on Revised Definition of Behavioral and Social Sciences Research at NIH
Clinical Trial Testing Fecal Microbiota Transplant for Recurrent Diarrheal Disease Begins
Gut microbes from healthy infants block milk allergy development in mice
Genes linked to abnormal bone density and fracture
Physical activity may reduce depression symptoms
School nutrition policies reduce weight gain
Notice of Change in Candidate Eligibility and Reporting Requirements for PAR-18-726 "NEI Institutional Mentored Physician Scientist Award (K12 Clinical Trial Optional)"
Notice of Change to RFA-HL-20-001 "Career Pathway to Independence in Blood Science Award for Physician Scientists (K99/R00 Independent Clinical Trial Not Allowed)"
Notice of Change in the NEI K08 Eligibility Requirements
Notice of Pre-Application Webinar: NIDCR Individual Mentored Fellowship (F) Awards
Notice of Pre-Application Webinar for PAR-17-341 "National Institute of General Medical Sciences Ruth L. Kirschstein NRSA Predoctoral Institutional Research Training Grant (T32)" and PAR-19-036 "Medical Scientist Training Program (T32)"
Notice of Pre-Application Webinar for PAR-19-102 "Graduate Research Training Initiative for Student Enhancement (G-RISE) (T32)"
Notice of Pre-Application Information Webinar for RFA-DA-19-029, RFA-DA-19-036, HEALthy Brain and Child Development (HEALthy BCD) Study
NCCIH Policy Change to Budget Limit and Grant Durations for SBIR/STTR Phase I and Phase II Applications
Notice of Change to RFA-HL-20-002 "Career Pathway to Independence in Blood Science Award for Physician Scientists (K99/R00 Independent Clinical Trial Required)"
Womens HIV Epidemiology Cohort Studies (R01 Clinical Trial Not Allowed)
NIH researchers rescue photoreceptors, prevent blindness in animal models of retinal degeneration
Notice of NHLBI Participation in PA-19-112 "Improving Outcomes in Cancer Treatment-Related Cardiotoxicity (R01 Clinical Trial Optional)"
Notice of NHLBI Participation in PA-19-111 "Improving Outcomes in Cancer Treatment-Related Cardiotoxicity (R21 Clinical Trial Optional)"
Notice of a Pre-Application Webinar for RFA-CA-19-007 and RFA-CA-19-008 on the Experimental Therapeutics Clinical Trials Network (ETCTN) (UM1) and ETCTN Pharmacokinetic Resource Laboratories (U24), respectively
Notice of Clarification of Eligibility for PAR-19-128
Notice of NINR Participation in PAR-18-714 " Academic Research Enhancement Award for Undergraduate-Focused Institutions (R15 - Clinical Trial Not Allowed)"
Notice of NINR Research Objectives added to PAR-19-134 "Research Enhancement Award Program (REAP) for Health Professional Schools and Graduate Schools (R15 Clinical Trial Not Allowed)"
New Findings Reveal Surprising Role of the Cerebellum in Reward and Social Behaviors
Innovations for Healthy Living - Improving Minority Health and Eliminating Health Disparities (R43/R44 - Clinical Trial Optional)
Notice of Clarification of the Percent Effort for PAR-18-679 NIAID Physician-Scientist Pathway to Independence Award (K99/R00 Clinical Trial Required)
Administrative Supplement for Research on Sex/Gender Influences (Admin Supp Clinical Trial Optional)
Notice of Extension of the Response Date for NOT-HL-18-660 "Request for Information (RFI): Understanding the Health of Women and the Role of Sex/Gender in Mechanisms of Heart, Lung, Blood, and Sleep Diseases and Disorders"
Development of New Technologies and Bioengineering Solutions for the Advancement of Cell Replacement Therapies for Type 1 Diabetes (R43/44 Clinical Trial Not Allowed)
Updated NIH Policy for Resubmission of New Investigator R01 Applications
Notice of Data Sharing Policy for the BRAIN Initiative
Notice of Change to Application Types for PAR-18-696, "Clinical Coordinating Center for NCCIH Multi-Site Investigator-Initiated Clinical Trials of Natural Products (Collaborative UG3/UH3 Clinical Trial Required)"
The National Institutes of Health (NIH) Sexual and Gender Minority Research Office (SGMRO) Announces Pacific Regional Workshop on Sexual and Gender Minority (SGM)-Related Research
Notice of Modifications to Instructions for Letters of Support in PAR-19-102 "Graduate Research Training Initiative for Student Enhancement (RISE) (T32)"
Notice of Change: Emphasizing Opportunity for Developing Comprehensive Human Genome Sequencing Methodologies in Response to NHGRI Novel Nucleic Acid Sequencing Technology Development FOAs
Notice of NIAAA's participation in PAR-19-134, Research Enhancement Award Program (REAP) for Health Professional Schools and Graduate Schools (R15 Clinical Trial Not Allowed)
Notice of Clarification: Funds Available for RFA-DE-19-008 Enabling Technologies to Accelerate Development of Oral Biodevices (R21 Clinical Trial Not Allowed)
Notice of Intent to Publish a Funding Opportunity Announcement for Medical Rehabilitation Research Resource (P2C Clinical Trial Optional)
Implementation of shared decision making for HLBS diseases and conditions (R01 Clinical Trial Optional)
Notice of Clarification: Funds Available for RFA-DE-19-009 Enabling Technologies to Accelerate Development of Oral Biodevices (R01 Clinical Trial Not Allowed)
Notice of Clarification of Eligibility for PAR-19-114 "Non-human Primates Facilities to Support HIV/AIDS-related Research (C06) (Clinical Trial Not Allowed)"
Notice of Change Application Due Date(s) for RFA-HD-19-024 "Womens HIV Epidemiology Cohort Studies (R01 - Clinical Trial Not Allowed)"
Notice of NIAAA's participation in NOT-OD-19-040 "Notice of Interest in Long-term Maintenance of Behavior Change Research"
Notice of NIAAA's participation in PAR-19-135, Research Enhancement Award Program (REAP) for Health Professional Schools and Graduate Schools (R15 Clinical Trial Required)
Notice of NIAAA's participation in PAR-19-133, Academic Research Enhancement Award for Undergraduate-Focused Institutions (R15-Clinical Trial Not Allowed)
Notice of Participation of the Office of Research on Womens Health (ORWH) in RFA-DA-19-029, HEAL Initiative: HEALthy Brain and Child Development Study (HEALthy BCD) (Collaborative R34 Clinical Trial Not Allowed) and RFA-DA-19-036, HEAL Initiative: HEA
Notice of NIA's Withdrawal from Participation in RFA-DK-18-031, "HEAL Initiative: Integrated Approach to Pain and Opioid Use in Hemodialysis Patients: The Hemodialysis Opioid Prescription Effort (HOPE) Consortium - Scientific and Data Research Center"
Natural Products NMR Open Data Exchange (NP-NODE) (U24 Clinical Trial Not Allowed)
Botanical Dietary Supplements Research Centers (U19 Clinical Trial Optional)
Center for Natural Product Technology, Methodology, and Productivity Optimization (NP-TEMPO) (U41 Clinical Trial Not Allowed)
Notice of NIA's Withdrawal from Participation in RFA-DK-18-030, "HEAL Initiative: Integrated Approach to Pain and Opioid Use in Hemodialysis Patients: The Hemodialysis Opioid Prescription Effort (HOPE) Consortium - Clinical Centers"
Faulty molecular master switch may contribute to AMD
Dengue immunity may be protective against symptomatic Zika, study finds
Notice of NHLBI Participation in PA-19-165 "Administrative Supplement for Research on Sex/Gender Influences (Admin Supp Clinical Trial Optional)"
Development and Validation of Advanced Mammalian Models for Alzheimers Disease-Related Dementias (ADRD) (R61/R33 Clinical Trial Not Allowed)
Notice of Pre-Application Webinar for the NIH Consortium for Advancing Research on Botanical and Other Natural Products (CARBON) Program: RFA-AT-19-002, RFA-AT-19-003 and RFA-OD-19-001
Notice of Intent to Publish the Reissuance of RFA-OD-18-002 "Tobacco Regulatory Science (R01 Clinical Trial Optional)"
Additional Information Regarding RFA-OD-18-001 "Tobacco Regulatory Science Small Grant Program for New Investigators (R03 Clinical Trial Optional)" and RFA-OD-18-003 "Tobacco Regulatory Science (R21 Clinical Trial Optional)"
Notice of Termination of PAR-19-164 "Summer Research Education Experience Program (R25 Clinical Trial Not Allowed)"
Establishing a Cohort to Clarify Risk and Protective Factors for Neurocognitive Complications of Pediatric Type 1 Diabetes (T1D) - Planning Cooperative Agreements (U34 Clinical Trial Not Allowed)
Mass Spectrometric Assays for the Reliable and Reproducible Detection of Proteins/Peptides of Importance in Obesity Research (U01 Clinical Trial Not Allowed)
Temperature-stable experimental tuberculosis vaccine enters clinical testing
New 2-Step Submission Process for RPPRs with Inclusion Enrollment Data
Blood test shows promise for early detection of severe lung-transplant rejection
Smoking linked to higher risk of peripheral artery disease in African-Americans
New fellowship program will support the next generation of African scientific leaders

About Us

The Population Aging Research Center (PARC) was established in 1994 with a grant from the National Institute on Aging, which fosters research on the demography and economics of health and aging. PARC sponsors an annual pilot proposal competition, a weekly seminar series in conjunction with the Population Studies Center and an online working paper series. The overall research themes of PARC reflect the interests and expertise of our research associates. These include: Health, Disease, and Mortality Risks at Older Ages, Early-life Conditions and Older Adult Health, Global Aging, Health Disparities, and Domestic/International Perspectives on Well-Being at Older Ages.

Quick Links

IRB & Human Subjects
NIH Public Access Policy
PSC Library Catalog
Sociology Department
Economics Department
DONATE TO THE PSC

Request Services

Reserve the PSC Conference Room and/or Collaboration Space
Submit a Working Paper
Submit News & Events

About Us

The Population Aging Research Center (PARC) was established in 1994 with a grant from the National Institute on Aging, which fosters research on the demography and economics of health and aging. PARC sponsors an annual pilot proposal competition, a weekly seminar series in conjunction with the Population Studies Center and an online working paper series. The overall research themes of PARC reflect the interests and expertise of our research associates. These include: Health, Disease, and Mortality Risks at Older Ages, Early-life Conditions and Older Adult Health, Global Aging, Health Disparities, and Domestic/International Perspectives on Well-Being at Older Ages.

Contact

Tel: 215-898-6441
Fax: 215-898-2124

239 McNeil Building
3718 Locust Walk
Philadelphia, PA 19104-6298
[Map & Directions]

twitter.com/pennparc

facebook.com/pennpsc

Penn A-Z - Penn Calendar

© 2019 The Trustees of the University of Pennsylvania

Population Studies Center